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Summary 
Regnase-1 and Roquin are RNA binding proteins essential for degradation of 
inflammation-related mRNAs and maintenance of immune homeostasis. However, their 
mechanistic relationship has yet to be clarified. Here we show that although Regnase-1 
and Roquin regulate an overlapping set of mRNAs via a common stem-loop structure, 
they function in distinct subcellular locations: ribosome/endoplasmic reticulum and 
processing-body/stress granules, respectively. Moreover, Regnase-1 specifically cleaves 
and degrades translationally active mRNAs and requires the helicase activity of UPF1, 
similar to the decay mechanisms of nonsense mRNAs. In contrast, Roquin controls 
translationally inactive mRNAs, independent of UPF1. Defects in both Regnase-1 and 
Roquin lead to large increases in their target mRNAs, although Regnase-1 tends to 
control the early phase of inflammation when mRNAs are more actively translated. Our 
findings reveal that differential regulation of mRNAs by Regnase-1 and Roquin 
depends on their translation status and enables elaborate control of inflammation.   
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Introduction 
Inflammation is mediated by proinflammatory cytokines such as tumor necrosis factor 
(TNF) and Interleukin 6 (IL-6). Expression of cytokines is rapidly induced in response 
to infection by pathogens via Toll-like receptors (TLRs) in innate immune cells 
(Chovatiya and Medzhitov, 2014; Moresco et al., 2011; Takeuchi and Akira, 2010). 
Whereas cytokine mRNA levels are controlled at both transcriptional and 
post-transcriptional levels, post-transcriptional dampening of protein expression in 
particular can resolve inflammation and prevent unintended tissue damage (Anderson, 
2010; Kafasla et al., 2014). Eukaryotic mRNAs are in dynamic equilibrium between 
different subcellular locations: actively translated mRNAs can be found in polysomes, 
mRNAs stalled in translation initiation can accumulate in stress granules (SGs), and 
mRNAs targeted for degradation or translation repression can accumulate in processing 
bodies (PBs). Further, mRNA-protein (mRNP) complexes dynamically move between 
polysomes, SGs and PBs (Anderson and Kedersha, 2009; Balagopal and Parker, 2009). 
Many immune-related mRNAs have short half-lives because of conserved 
cis-elements including AU-rich elements (AREs) and stem-loop (SL) structures in their 
3′ untranslated regions (UTRs) (Anderson, 2010; Kafasla et al., 2014). ARE binding 
proteins are involved in controlling the stability of such mRNAs. In addition, SLs 
present in mRNAs including ICOS, OX40 and TNF are destabilized by Roquin-1 and -2 
(Leppek et al., 2013). These proteins harbor an RNA binding ROQ domain whose loss 
of function mutation (M199R) in mice (San) leads to the development of autoimmune 
disease characterized by an increase in follicular helper T cells (Linterman et al., 2009; 
Vinuesa et al., 2005; Yu et al., 2007). ARE- and Roquin-mediated mRNA decay takes 
place in PBs or SGs where a CCR4-CAF1-NOT deadenylase complex is recruited 
(Anderson, 2010; Athanasopoulos et al., 2010). 
In contrast, another set of mRNA decay pathways target mRNAs undergoing 
translation. In the nonsense mediated decay (NMD), premature translation termination 
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at more than 20-25 bases 5′ of the exon junction complex (EJC) promotes the 
recruitment of an SMG1-UPF1-eRF1-eRF3 (SURF) complex (Kervestin and Jacobson, 
2012; Popp and Maquat, 2013; Schweingruber et al., 2013). The SURF complex then 
interacts with the UPF2-UPF3-EJC complex, leading to recruitment of the 
endonucleases SMG6, SMG5 and SMG7, which mediate deadenylation for further 
degradation. In addition, active translation and UPF1 are required for some normal 
mRNA decay pathways, including staufen1-mediated mRNA decay (SMD) and 
replication-dependent histone mRNA decay (Kaygun and Marzluff, 2005; Kim et al., 
2005). 
 We identified Regnase-1 (Reg1; also known as Zc3h12a and Mcpip1) as an 
RNase critical for preventing a severe autoimmune inflammatory disease in mice by 
destabilizing inflammation-related mRNAs (Iwasaki et al., 2011; Matsushita et al., 
2009). Reg1 harbors a PIN-like RNase domain, and controls a set of genes including Il6 
and Reg1 itself, but not Nfkbia, in macrophages following stimulation with TLR ligands 
such as lipopolysaccharide (LPS) and IL-1, which activate shared signaling pathways. 
Reg1 is also essential for suppressing aberrant activation of T cells by targeting genes 
such as Icos, c-Rel and Ox40 for degradation (Uehata et al., 2013). 
In this study, we aim to uncover how Reg1 recognizes and degrades its target 
mRNAs, and show that Reg1 interacts with a set of SL-containing mRNAs that overlaps 
with those targeted by Roquin. In contrast to Roquin, Reg1 co-localizes with ribosomes, 
but not with PBs and SGs. Reg1 destabilizes translationally active mRNAs, and requires 
UPF1. The apparent cooperation between Reg1 and Roquin is confirmed by the 
upregulation of their mutual target mRNAs under mutation of both Reg1 and Roquin, 
although Reg1 and Roquin tend to control the early and late phases of inflammation, 
respectively. Thus, a common set of SL-containing mRNAs are recognized by distinct 
proteins in different stages of mRNA metabolism for fine tuning of immune responses. 
T. Mino et al.  
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Results 
SL structure required for Reg1-RNA association. 
We previously showed that a potential SL sequence in the Il6 3′UTR (84-102) is 
recognized by Reg1 for degradation (Matsushita et al., 2009). To determine the 
secondary structure of the Il6 3′UTR target sequence, we performed selective 
2′-hydroxyl acylation analyzed by primer extension (SHAPE) analysis. The SHAPE 
results were consistent with the computational prediction of a simple SL structure with 
bulge (Figure 1A and 1B). We then examined if the SL is critical for the control of Il6 
expression by Reg1 by using an antisense morpholino that can interfere with SL 
formation in Il6 3′UTR (Il6-SL-MO) (Figure 1C). A luciferase assay expressing the 
reporter construct with the Il6 3′UTR, the morpholinos, and Reg1 revealed that the 
suppression of the luciferase activity observed in control (Ctrl) morpholino transfected 
cells was cancelled by the Il6-SL-MO (Figure 1D). Following introduction of the 
Il6-SL-MO to mouse bone marrow macrophages (BMMs), LPS-induced expression of 
mRNA and protein for IL-6, but not TNF, were significantly elevated compared with 
control cells (Figure 1E). We further supplemented Il6–/– mice with wild-type (WT) 
BMM treated with the Il6-SL-MO. LPS-induced production of IL-6, but not TNF, in the 
sera was elevated in mice supplemented with Il6-SL-MO-treated BMM, indicating that 
the SL in the Il6 3′ UTR is important for the regulation of IL-6 production in vivo 
(Figure 1F). 
To investigate if the conserved SL is required for processing by Reg1, which 
harbors endonuclease activity as shown by the digestion of circular RNA in vitro 
(Figure S1A and S1B), we synthesized Il6 3′UTR RNAs with and without the SL 
(Figure S1C). Reg1 degraded RNAs harboring the SL, but not without the SL (Figure 
S1C), suggesting that the SL is required for RNase-mediated digestion or RNA binding. 
To distinguish between these two possibilities, we artificially tethered Reg1 to Il6 
coding and luciferase mRNAs using the N-BoxB system (Figure 1G). Interestingly, a 
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N-Reg1, but not WT Reg1, destabilized the Il6 coding sequence in the presence of 
5XBoxB in the Tet-off system (Figure 1H and 1I). This was further confirmed by a 
luciferase reporter assay expressing the luciferase construct with 5XBoxB in the 3′ UTR 
and N-Reg1 (Figure S1D), indicating that the SL is required for the recruitment of 
target mRNAs by Reg1, but is dispensable for their degradation. 
To check the possibility of Reg1-mediated control of miRNA generation 
(Suzuki et al., 2011), we prepared small RNAs from Reg1–/– mouse embryonic 
fibroblasts (MEFs). QPCR analysis revealed that the levels of miRNAs previously 
reported to be regulated by Reg1 as well as a set of LPS-inducible miRNAs including 
miR-155 and miR-146a did not increase in the absence of Reg1 (Figure S1E), indicating 
that Reg1 is dispensable for the control of these miRNAs. 
 
Identification of mRNAs associating with Reg1. 
To comprehensively identify mRNAs associated with Reg1, we performed 
RNA-immunoprecipitation (IP) sequencing (RIP-Seq) analysis. We expressed 
Flag-Reg1 lacking RNase activity (D141N), which was predicted to retain RNA binding 
activity (Figure S1F), in HeLa cells. We found that IL6 and Reg1 (ZC3H12A) were 
highly enriched by IP with Reg1 compared with control IP, both in unstimulated and 
IL-1-stimulated cells (Figure 1J and Table S1), indicating that IP with Reg1 properly 
co-precipitated its target mRNAs. A total of 68 mRNAs were significantly enriched 
either in unstimulated or IL-1-stimulated cells (p values < 10–3) compared with control 
cells (Table S1). Gene ontology annotations enriched for the 68 Reg1-interacting 
mRNAs were often involved in inflammation (Table S2). 
We then investigated if the Reg1-binding mRNAs were targeted by Reg1 for 
degradation. We constructed luciferase reporter genes with 3′UTRs from a set of 
enriched genes including Nfkbiz, Nfkbid, Ptgs2, Mafk, Id1, Cxcl1, Cxcl2 and Cxcl3. 
Overexpression of Reg1 suppressed the luciferase activity in an RNase-activity 
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dependent manner (Figure 1K). Consistent with a previous report (Iwasaki et al., 2011), 
overexpression of Reg1 suppressed Reg1 3′ UTR containing nucleotides 1-210, but not 
in the case where nucleotides 1-200, which contains the SL, were absent. Collectively, 
Reg1-bound mRNAs obtained by RIP-Seq are indeed targeted by Reg1 for degradation. 
 
The Reg1 target consensus motif overlaps with that of Roquin. 
Roquin-1 was also reported to associate with SL containing mRNAs such as Tnf, Icos, 
Nfkbid and Nfkbiz in RAW264.7 cells (Leppek et al., 2013). Indeed, overexpression of 
Roquin suppressed the luciferase activity in the presence of the 3′UTR of Nfkbiz, Nfkbid 
and Ptgs2 (Figure S1G), suggesting an overlap between Reg1 and Roquin target 
mRNAs.  
We therefore next examined Roquin-interacting mRNAs globally in HeLa cells 
by RIP-Seq analysis. A total of 52 high-confidence mRNAs were enriched by IP with 
Flag-Roquin either in unstimulated or IL-1-stimulated cells (p values < 0.01) (Table 
S3). Gene Set Enrichment Analysis (GSEA) showed that 68 Reg1 targets (p ≤ 1.0 X 
10–3) were significantly biased toward high enrichment scores (ES) in the Roquin 
RIP-seq data (P < 1 X 10–4; Figure 2A). We found a similar significant enrichment of 
Reg1 targets among mRNAs enriched in the Roquin RIP-seq sample when using the 
Kolmogorov-Smirnov test (P < 2.2 X 10–16). Reciprocally, the set of 52 high-confidence 
Roquin targets (p ≤ 0.01) showed a significant overlap with mRNAs enriched in the 
Reg1 RIP-seq data (P < 1 X 10–4; Figure 2B). These 52 Roquin targets shared 10 
mRNAs with the 68 Reg1 targets (P = 2.69 X 10–15). These results demonstrate that the 
Reg1 and Roquin target mRNAs overlap significantly.  
Among newly identified Reg1-associated mRNAs, we focused on two mRNAs, 
Nfkbiz and Ptgs2. By testing luciferase constructs with truncated Nfkbiz 3′UTRs (Figure 
S2A), we found that Nfkbiz (100-150), which is evolutionally conserved and predicted 
to contain 2 SLs (Figure S2B and S2C), is required for Reg1-mediated suppression. 
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Addition of either one of these SL to the -globin 3′UTR conferred responsiveness to 
Reg1 (Figure S2D). Similarly, we found that Ptgs2 (1000-1300) was required for the 
regulation by Reg1 (Figure S2E). Mouse Ptgs2 (1211-1228) was predicted and shown to 
form a conserved SL (Figure S2F-S2H), and this sequence alone was sufficient for Reg1 
to suppress luciferase activity (Figure S2I). In addition, we found that a luciferase 
construct with the constitutive decay element (CDE) present in Tnf mRNA, which was 
identified as a Roquin target SL (Leppek et al., 2013), and SL alone (TNF-CDE37) was 
suppressed by Reg1 (Figure 2C and S2J).  
Next, we investigated target structures present in Reg1 binding mRNAs 
globally by high-throughput sequencing of RNA isolated by crosslinking 
immunoprecipitation (HITS-CLIP) in HEK293 cells (chosen because of their wide 
usage in CLIP analysis) with stable, inducible expression of Flag-tagged WT Reg1 
(Figure 2D). UV-crosslinked RNAs co-precipitated with Flag-Reg1 were recovered and 
sequenced. By analyzing sequence data of two biological replicate libraries, we 
identified 9107 and 10448 putative Reg1 binding groups in two biological duplicate 
libraries, respectively (Table S4). The two libraries intersected on a group level with at 
least one overlapping nucleotide; we thereby obtained 1143 Reg1 binding sites. As 
expected, many sites were located in 3′UTRs, although some fractions were mapped to 
coding regions and introns (Figure 2E). Although immune-related mRNAs were not 
frequently observed in HEK293 cells because of their poor expression, we identified 
Reg1 target sites in genes such as TM2D3, which was identified by RIP-seq analysis. 
The obtained sequences from them were predicted to form SLs (Figure 2F), and were 
suppressed by Reg1 (Figure 2G). When the Reg1 binding sequences were globally 
folded using RNAfold, SL structures with 3-7 nucleotide stems and 3 nucleotide loops 
were significantly enriched compared with 1000 individual permutations in both of the 
replicates and their intersection (p < 0.001) (Figure 2H). Next, we investigated the 
sequence motifs enriched in the Reg1 binding SLs harboring a hairpin of 3 nucleotides 
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with varying stem lengths (3, 5 or 7 nucleotides). Interestingly, the UAU sequence was 
significantly enriched in the hairpin sequences (Figure 2I). 
Next, we examined the requirement of the SL structure and the specific hairpin 
loop sequence for Reg1-mediated target mRNA suppression. Using two validated SLs, 
TNF-CDE and another artificial SL with an UAU loop (Figure S3A-S3C), we first 
analyzed the importance of SL structures. Disruption of the SL structures abrogated 
Reg1-mediated suppression, and restoration of the SL structure by mutating both sides 
of the stem resulted in rescue of Reg1-mediated suppression (Figure S3D and S3E). We 
then generated a set of luciferase constructs harboring SLs with different loop sequences. 
In addition to SLs with UAU, UGU loop sequences were significantly inhibited by 
Reg1 overexpression (Figure 2J), indicating that SL sequences with either A or G at the 
second residue in the hairpin loop can be suppressed by Reg1. In contrast, ACA, AAA 
or UCU SLs were not suppressed by Reg1 expression, suggesting that a 
pyrimidine-purine-pyrimidine (Py-Pu-Py) sequence should be present in the loop. 
Furthermore, IP with Reg1 co-precipitated reporter mRNA with a SL structure, 
while reporters whose SL was disrupted no longer co-precipitated with Reg1 (Figure 
S3F and S3G), indicating that the SL structure is required for Reg1 binding in cells. 
Additionally, alteration in the loop sequence abrogated its binding with Reg1 (Figure 
S3H).  
Reciprocally, Roquin overexpression suppressed the luciferase activity and 
mRNA with -globin 3′UTR followed by Reg1 target SL sequences (Figure 2K). Taken 
together, these results demonstrate that Reg1 and Roquin can recognize overlapping 
target mRNAs via the same SLs present in their 3′UTRs. 
 
Reg1 localizes to the endoplasmic reticulum (ER), but not PBs or SGs. 
The fact that Reg1 and Roquin recognize the same SL prompted us to investigate their 
relationship further. We first examined the involvement of deadenylation and decapping 
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in Reg1-mediated mRNA decay by overexpressing dominant negative mutants of Caf1 
(Caf1-AA), and Dcp2 (Dcp2-AA). In contrast to Roquin-1 and -2, neither Caf1-AA nor 
Dcp2-AA affected Reg1-mediated degradation of Il6 mRNA (Figure S4A).  
We next investigated if Reg1 and Roquin function in the same subcellular 
location. Immunofluorescence staining revealed that Roquin-1 localizes in PBs in 
NIH3T3 and HeLa cells and in SGs upon arsenite treatment (Figure S4B and S4C). In 
contrast, NIH3T3 cells expressing Flag-Reg1 did not localize to PBs, or SGs upon 
arsenite treatment (Figure 3A and Figure S4D). In contrast, Reg1 co-localized with 
Calnexin, a type I membrane protein of the ER, but not with disulfide isomerase (PDI), 
a protein found within the ER (Figure 3B and S4E), indicating that Reg1 localizes on 
the surface of the ER. Because the surface of the rough ER (RER) is studded with 
ribosomes, we next demonstrated that Reg1 also co-localizes to the ribosome (Figure 
3B and S4E). Moreover, immunoelectron microscopy analysis revealed that Reg1 
localized to the cytoplasm and the surface of the ER (Figure 3C). Furthermore, 
subcellular fractionation of NIH3T3 cells revealed that endogenous Reg1 was present in 
the cytosol and RER, but not smooth ER, which does not contain ribosomes (Figure 
3D).  
 To further investigate whether Reg1 localizes to translationally active 
polysomes, HeLa cell lysates were subjected to polysome fractionations (Figure 3E). 
Immunoblot analysis revealed that endogenous Reg1 localized in polysomal fractions in 
addition to non-polysome (non-ribosome and 40S-80S) fractions (Figure 3E), though 
Roquin-1 and -2 were localized in the non-polysome fractions. 
 
Reg1, but not Roquin, regulates target mRNAs in the polysomal fraction. 
Next we extracted RNAs from ribosomal fractions in HeLa cells following Reg1 and 
Roquin-1/-2 siRNA treatment with or without IL-1 stimulation, and examined the 
levels of mRNA expression in each fraction (Figure 3F and 3G). Reg1 and Roquin-1/-2 
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were efficiently suppressed at the mRNA and protein levels (Figure 3G and data not 
shown). Knockdown of Reg1 resulted in a large increase in IL6 and PTGS2 mRNA 
expression in the polysome fractions (fractions 7-12) compared with control cells, 
whereas the mRNA in non-polysome fractions (fractions 3-6) were comparable (Figure 
3H). However, TNF and NFKBIA expression was unchanged in Reg1 knockdown. In 
contrast, TNF and PTGS2 increased in Roquin-1/-2 knockdown cells. Interestingly, the 
increase was observed in non-polysome fractions, but not in polysome fractions (Figure 
3H).  
 We further detected PTGS2 in HeLa cells by using in situ hybridization 
following IL-1 stimulation (Figure S4F). Knockdown of Reg1 and Roquin-1/2 resulted 
in an increase in PTGS2 expression (Figure S4F and S4G). Whereas Reg1 knockdown 
decreased PTGS2 localized in the PB, Roquin-1/-2 knockdown increased PTGS2 
localized in PBs (Figure S4F and S4H). Taken together, these results demonstrate that 
Reg1 is critical for controlling the expression of translationally active mRNAs, whereas 
Roquin-1/2 regulate translationally inactive mRNAs in PBs/SGs.  
 
Reg1 destabilizes translationally active mRNA via stop codons. 
We next treated Reg1–/– macrophages with protein translation inhibitors, anisomycin and 
cycloheximide (CHX), and examined the kinetics of Il6 and Ptgs2 mRNA degradation 
after stimulation with LPS. Whereas Il6 and Ptgs2 mRNAs were stabilized in Reg1–/– 
macrophages compared with WT, the difference was lost following treatment with 
anisomycin or CHX (Figure 4A). Reciprocally, destabilization of Il6 mRNA induced by 
Reg1 overexpression was no longer observed in response to treatment with these protein 
synthesis inhibitors (Figure 4B and 4C). The translation inhibitors did not alter Reg1 
cellular localization or its protein expression levels (Figure S5A and S5B). 
 We next examined the effect of Reg1 on translationally inactive mRNA. We 
inserted a highly stable SL (SSL), which was shown to inhibit translation (Doma and 
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Parker, 2006), immediately upstream of the start codon of luciferase or Il6 (Figure 4D). 
Insertion of the SSL to the luciferase reporter resulted in severe decrease in luciferase 
activity, but not in its mRNA, suggesting that the SSL suppressed protein synthesis 
(Figure 4E). Overexpression of Reg1 no longer destabilized Il6 with the SSL in the 
5′UTR (Figure 4F and 4G), further confirming that active translation is essential for 
Reg1-mediated mRNA decay. 
 However, Reg1-mediated mRNA destabilization was not affected by the 
presence of IRES at the 5′UTR (Figure S5C and S5D), suggesting that translation 
initiation is dispensable for the function of Reg1. In contrast, Reg1 failed to destabilize 
an Il6 whose stop codons were mutated throughout the 3′UTR (Il6 mRNA-STOP) and 
luciferase Il6 3′UTR without a stop codon (Figure 4F-4H). Requirement of stop codons 
in the Reg1-mediated mRNA decay prompted us to hypothesize that the distance 
between the stop codon and the Il6 mRNA SL is important for Reg1–mediated 
destabilization. To examine this, we prepared Il6 constructs harboring different 
distances between the stop codon and the SL (Figure 4I). Reg1 destabilized Il6 mRNA 
with its original 3′UTR with (1-125), but not without (1-81), a SL (Figure 4J). Although 
the construct harboring the SL 23 bases downstream of the stop codon (64-125) was still 
suppressed by Reg1, those with the SL immediately downstream of the stop codon 
(82-125) were not (Figure 4J). These data suggest that the stop codon and SL structure 
require a minimal distance (about >20 nt) to be suppressed by Reg1.  
 
Reg1 associates with ribosome proteins and UPF1. 
Next we explored Reg1-associated proteins with a global proteomics approach using 
iTRAQ (Figure 5A). Levels of many ribosomal proteins in Reg1 immunoprecipitates 
from HeLa and RAW cells expressing Flag-Reg1 increased compared to control cells 
(Figure 5B and Table S5). Consistently, recombinant Reg1 precipitated by 
ultracentrifugation when incubated with highly-purified ribosome in vitro (Figure 5C), 
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suggesting that Reg1 is physically associated with the ribosome. 
In addition to ribosomal proteins, we found that Flag-Reg1 co-precipitated 
UPF1 irrespective of Benzonase treatment (Figure 5B and 5D), suggesting that Reg1 
and UPF1 exhibit direct protein-protein interaction. Whereas Reg1 lacking the 
N-terminal helical domain (90-596) (Figure 5E) was able to bind UPF1 (Figure 5F), 
Reg1 including the RNase domain to the C-terminal end (130-596) or only the 
C-terminal region (331-596) failed to co-precipitate UPF1 (Figure 5F). In contrast, 
Reg1 lacking the linker region between the N-terminal helical domain and the RNase 
domain (90-130) showed severely impaired interaction with UPF1 (Figure 5F). 
Furthermore, overexpression of Reg1 (90-130) lost the competency to suppress Il6 and 
Ptgs2 3′UTR (Figure 5G), suggesting that the interaction between Reg1 and UPF1 is 
essential for Reg1 function. 
 
UPF1 is critical for Reg1-mediated mRNA decay via its helicase activity. 
Next we examined if UPF1 is required for Reg1-mediated decay. When we knocked 
down UPF1 in HEK293 cells, overexpressed Reg1 failed to degrade Il6 (Figure 6A and 
6B). Furthermore, Reg1 overexpression no longer suppressed the luciferase reporter 
constructs harboring 3′UTRs for IL6, PTGS2, ICOS and TNF-CDE37 in HeLa and 
RAW264.7 cells (Figure 6C and Figure S6A and S6B). In contrast, knockdown of UPF2 
and UPF3x did not affect Reg1-mediated suppression (Figure 6C and Figure S6B). 
Further, the response to Roquin overexpression was not inhibited by the loss of UPF1 
(Figure 6D and Figure S6C), indicating that Reg1 and Roquin degrade target mRNA in 
UPF1-dependent and –independent manners, respectively. Interestingly, knockdown of 
UPF1 or Reg1 in HeLa and RAW264.1 cells resulted in increased expression of IL6 and 
PTGS2, but not NFKBIA, in response to IL-1 or LPS stimulation, respectively (Figure 
6E and S6D). Knockdown of UPF1, but not Reg1, resulted in an increase in 
NMD-target genes such as SMG5 and GAS5 (Figure 6E and S6D). 
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 Whereas overexpressed Reg1 co-precipitated Il6, UPF1 knockdown increased 
the amounts of Il6 co-precipitated with Reg1 (Figure 6F). Knockdown of UPF1 
abrogated Reg1-mediated inhibition, even when we tethered Reg1 to the target mRNA 
(Figure S6E and Figure 6G), indicating that UPF1 is required for Reg1 to cleave its 
target mRNAs after binding. Furthermore, anisomycin treatment abrogated the 
N-Reg1-mediated suppression of Il6-5XBoxB expression (Figure 6H) without 
inhibiting the Reg1-Il6 interaction (Figure S6F), indicating that translation is required 
for Reg1 to degrade associated mRNAs. The interaction between Reg1 and UPF1 was 
inhibited by the treatment with anisomycin (Figure 6I), suggesting that the association 
between Reg1 and UPF1 is mediated by translation. 
 We next examined the role of UPF1 helicase activity in controlling Reg1. We 
depleted endogenous UPF1 with siRNA and reconstituted it with exogenous 
siRNA-resistant WT and helicase inactive (D648A/E649A; DEAA) (Franks et al., 2010) 
mutant UPF1 in HeLa cells (Figure 6J). WT, but not the DEAA, rescued Reg1-mediated 
suppression of Il6 3′UTR (Figure 6K). Furthermore, IL-1-mediated expression of IL6 
and PTGS2 was suppressed by the UPF1 reconstitution in a manner dependent on the 
helicase activity (Figure 6L). Nevertheless, the UPF1 DEAA was capable of interacting 
with Reg1 (Figure S6G), indicating that the UPF1 helicase activity is required for Reg1 
at the degradation step of its target mRNAs. Collectively, these results demonstrate that 
UPF1 interacts with Reg1 upon translation, and is essential for Reg1-mediated 
degradation of target mRNAs after recognition by acting as an RNA helicase. 
 
Cooperative and distinct roles of Reg1 and Roquin in inflammatory gene 
expression. 
Since Reg1 and Roquin suppress common target mRNAs via distinct molecular 
mechanisms, we investigated their relationship by expressing mutant Reg1 and Roquin 
in the same cells. First, we observed that the Reg1 D141N localized in SGs in addition 
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to ER following arsenite treatment (Figure S7A). Interestingly, the Reg1 D141N mutant 
cancelled suppression of luciferase reporter constructs harboring 3′UTRs for Il6 
(86-102) and Ptgs2 3′UTR by Roquin overexpression (Figure S7B). In contrast, 
Roquin-NT, whose localization is consistent with WT Roquin (data not shown), failed 
to alter Reg1-mediated suppression (Figure S7B). These results suggest that Reg1 and 
Roquin affect the same SL, and that the Reg1 D141N mutant stays on the 3′UTR and 
thereby inhibits the action of Roquin. 
We further examined the roles of Reg1 and Roquin by generating BMMs 
harboring Reg1–/– and Roquin-1San/San alleles. We found that the expression of Il6 and 
Tnf upon LPS stimulation was augmented in Reg1–/– and Roquin-1San/San BMM, 
respectively (Figure 7A). Further, Ptgs2 mRNA increased in Reg1–/– and Roquin-1San/San 
BMM. Since Il6, Tnf and Ptgs2 mRNAs present in polysomal fractions rapidly 
increased in response to IL-1 stimulation in HeLa cells and then decreased at later time 
points (Figure 3H and S7C), we hypothesized that the contribution of 
translation-dependent decay by Reg1 changes in the time-course of BMM activation. 
Indeed, the difference in Il6 and Ptgs2 expression between WT and Reg1–/– BMM was 
more obvious 1 or 2 h after LPS stimulation than 8 h post stimulation (Figure 7A). In 
contrast, the difference in Tnf and Ptgs2 expression in WT and Roquin-1San/San BMM 
was greater 4 and 8 h after LPS than at earlier time points. These data demonstrate that 
Reg1 and Roquin play more important roles earlier and later, respectively, in response to 
TLR stimulation. Consistent with the Ptgs2 mRNA expression results, Ptgs2 protein 
was expressed more abundantly in Reg1–/– BMM 2 h after LPS stimulation compared 
with WT (Figure 7B). In contrast, the expression of Ptgs2 protein in Roquin-1San/San 
BMM increased greatly 8 h after stimulation. Furthermore, the Ptgs2 protein/mRNA 
ratio was higher in Reg1–/– BMM compared with WT and Roquin-1San/San cells (Figure 
7C). These results are consistent with the increased expression of Ptgs2 mRNAs in 
polysomal fractions in HeLa cells with defective expression of Reg1 (Figure 3H). 
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Although Reg1–/–; Roquin-1San/San double mutant mice were mostly embryonic 
lethal (data not shown), we successfully established MEFs with the Reg1–/–; 
RoquinSan/San genotype. In response to LPS and TNF stimulation in WT MEFs, the 
expression of genes including Il6, Tnf and Ptgs2 was upregulated (Figure 7D and S7D). 
MEFs lacking Reg1 showed increased expression of Il6 and Ptgs2 compared with WT, 
particularly in the early phase of the responses (Figure 7D). Similarly, the Roquin San 
mutation resulted in an increase in the expression of Tnf, Il6 and Ptgs2 at later time 
points after LPS stimulation (Figure 7D). Interestingly, Reg1–/–; RoquinSan/San MEFs 
showed high increases in the expression of Il6, Tnf and Ptgs2 mRNAs both in early and 
late phases, suggesting that Reg1 and Roquin in part redundantly regulate their target 
mRNAs, although Nfkbia expression was not altered (Figure 7D and S7D). 
Finally, we examined the genome-wide changes in gene expression in WT, 
Reg1–/–, Roquin-1San/San and Reg1–/–; Roquin-1San/San MEFs with or without LPS 
stimulation by transcriptome analysis (Table S6). A set of genes was greatly increased in 
Reg1–/–; Roquin-1San/San double mutant MEFs compared with WT (Figure S7E). GSEA 
revealed that the mouse counterparts of Reg1- and Roquin-binding mRNAs identified 
by RIP-sequencing analysis were significantly enriched in genes more abundantly 
expressed in Reg1–/–; Roquin-1San/San, Reg1–/– and Roquin-1San/San MEFs (Figure 7E, 7F 
and Figure S7F). These results indicate that the Reg1- and Roquin-binding mRNAs are 
commonly regulated by these RNA binding proteins. 
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Discussion 
In this study, we found that Reg1 and Roquin target overlapping mRNAs and SLs for 
degradation. Nevertheless, they degrade the target mRNAs using different molecular 
mechanisms and in different cellular locations. Whereas Roquin localizes in PBs/SGs 
and degrades mRNAs via deadenylation like other mRNA decay pathways, Reg1 
associates with ribosomes, and degrades mRNAs in a translation-dependent manner 
(Figure 7G).  
The UAU loop sequence was enriched in Reg1-binding sites, and the loop 
sequence was important for Reg1-mediated mRNA decay. So far, all validated Reg1 
target SLs contain a Py-Pu-Py loop sequence, and mutation of this loop sequence results 
in Reg1 unresponsiveness, a rule shared by Roquin target mRNAs. We did not find a 
specific rule in the stem-sequence of Reg1-target mRNAs, although Roquin target stem 
sequences were reported to harbor the UUG sequence in their upper stem. One 
possibility is that Reg1 can recognize a broader range of SL structures than Roquin. 
However, crystal structures studies revealed that Roquin ROQ domain interacts with the 
TNF-CDE stem and a triloop with Py-Pu-Py sequences, and that Roquin uses mainly 
non-sequence-specific contacts with the RNA (Schlundt et al., 2014; Schuetz et al., 
2014; Tan et al., 2014). Indeed, we found that overexpression of Roquin could affect 3′ 
UTRs harboring a stem without the UUC sequence. Therefore, the requirement for 
particular stem sequences may not be so strict, and SL structures harboring a Py-Pu-Py 
loop sequence might be more broadly recognized by both Reg1 and Roquin. 
Reg1 and Roquin negatively regulate activation of T cells in addition to the 
control of inflammatory gene expression in innate immune cells (Pratama et al., 2013; 
Uehata et al., 2013; Vogel et al., 2013). Icos is a common target of Reg1 and Roquin 
proteins, and we found that a SL structure present in its 3′UTR is recognized by both 
Reg1 and Roquin. A recent report showed that Nfkbiz and Nfkbid are suppressed by 
Reg1 and Roquin in T cells, controlling Th17 differentiation, although their relationship 
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was not studied (Jeltsch et al., 2014). We focused on the mechanisms in innate immune 
and non-immune cells in this study; however, it is likely that Reg1 and Roquin similarly 
regulate mRNAs related to T cell activation in a manner dependent on the state of 
translation. Since lethality upon mutation of both Reg1 and Roquin prohibited analyzing 
their roles in adult T cells, it would be interesting to analyze their functional roles in T 
cells by using conditional alleles in the future. 
We found that Reg1-mediated mRNA decay requires translation and translation 
termination approximately 20 bases or more upstream of the SL. Similar to NMD, the 
stop codon might be required for preventing the disruption of the SL by the ribosome. In 
addition, the requirement of UPF1 demonstrates that the Reg1-mediated decay 
mechanism is highly similar to that of the quality control pathway, NMD. In the 
execution of NMD, endonucleolytic cleavage by SMG6 as well as exonucleolytic 
cleavage induced by the complex of SMG5-SMG7 contributes to the degradation of 
aberrant mRNAs (Eberle et al., 2009; Loh et al., 2013). SMG6-cleaved mRNA product 
can be further degraded in a manner dependent on the exosome and XRN1 exonucleases. 
Since Reg1 serves as an endonuclease like SMG6, a similar complete mRNA 
degradation system might operate upon cleavage by Reg1. 
An open question is why Reg1-mediated mRNA decay requires active 
translation. Given that translation-inactive mRNAs are not affected by the absence of 
Reg1, this mechanism may be beneficial for maintaining a certain reserve of 
inflammation-related mRNAs. If Reg1 were to arbitrarily degrade its target mRNAs 
irrespective of their translation status, immune-related mRNA levels might become very 
low and additional energy would be required for de novo transcription. Alternatively, 
this mechanism may lead to the production of one protein per mRNA to keep control of 
short half-lives of Reg1-target mRNAs. In contrast, Roquin-mediated decay is involved 
in the constitutive decay of mRNAs and can be important for the regulation of the 
amounts of stored immune-related mRNAs. The presence of different regulatory 
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proteins makes posttranslational control of inflammation more elaborate than previously 
realized.  
Although UPF1 is essential for NMD, the molecular mechanisms how UPF1 is 
involved in NMD are still under debate. In one model, UPF1 is recruited to the mRNP 
complex upon translation termination forming a SURF complex (Kurosaki and Maquat, 
2013), and the helicase activity of UPF1 is proposed to be required for the disassembly 
of the mRNP complex (Franks et al., 2010). However, this model was challenged in 
reports demonstrating that UPF1 is associated with mRNAs even before translation 
(Hogg and Goff, 2010; Hurt et al., 2013; Zund et al., 2013). The helicase activity of 
UPF1 is essential for Reg1-mediated cleavage of target mRNAs, although this activity 
is dispensable for Reg1 to interact with its target mRNAs. Therefore, the Reg1-UPF1 
interaction is possibly induced in the course of translation irrespective of UPF1 helicase 
activity, which may potentiate the RNase activity of Reg1 by remodeling an mRNP 
complex (Figure 7G). 
Reg1-mediated decay is dependent on UPF1, but not on UPF2 and UPF3x. 
Whereas all three UPF members are required for NMD, UPF2 and UPF3x are also 
dispensable for SMD and replication-dependent histone mRNA decay (Kaygun and 
Marzluff, 2005; Kim et al., 2005). Nevertheless, Staufen 1 and 2 are sensors for 
recognizing dsRNA sequences (Park et al., 2013), but do not have RNase activity. 
Staufen1 was dispensable for the Reg1-mediated decay (data not shown), and 
Reg1-mediated mRNA decay is highly unique in that Reg1 serves as both a sensor for 
the SL and a degradation enzyme simultaneously. 
Although loss of function of both Reg1 and Roquin-1/-2 resulted in a large 
increase in the expression of Tnf, Il6 and Ptgs2, dysfunction of Reg1 or Roquin alone 
seems to differentially regulate Il6 and Tnf, respectively. Further, both Reg1 and 
Roquin-1 suppressed Tnf and Il6 mRNA 3′ UTRs upon overexpression; thus, it is 
currently difficult to explain why Tnf expression did not increase under Reg1 deficiency. 
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Since Reg1 is critical for the regulation of Tnf in the absence of Roquin, Roquin may 
bind with the Tnf SL more strongly than Reg1 and thus reduce the accessibility of Reg1 
to Tnf mRNA. Furthermore, it would not be surprising if the translation status 
dynamically changes in the course of the life of an mRNA. Further studies will uncover 
the mechanisms of dynamic cellular regulation of mRNA translation status in relation to 
mRNA decay. 
Collectively, this study clearly demonstrates that the posttranscriptional 
regulation of inflammation is controlled by Reg1 and Roquin in spatiotemporally 
distinct manners. Given that excess and prolonged production of cytokines leads to the 
onset of inflammatory diseases, prolonged stability of inflammatory cytokine mRNAs 
can be considered aberrant, and thus targeted by the quality control system. Differential 
regulation of Reg1- and Roquin-mediated mRNA degradation are thus necessary for the 
elaborate control of inflammation. 
 




HeLa expressing Flag-Reg1-D141N, Roquin-1 or an empty vector were stimulated with 
human IL-1 (10 ng/mL) for 2 h. RNA-protein complexes were immunoprecipitated 
with anti-Flag antibody (F3165; Sigma) bound to protein G magnetic beads and RNAs 
were extracted from the beads. RNA library was prepared using Small RNA Sample 
Prep kit v1.0 (Illumina Inc.) and sequenced on a HiSeq 2000 system (Illumina) also 
according to the manufacturer’s instructions. The resulting set of trimmed reads were 
then mapped against the human genome (hg19; NCBI). 
 
mRNA decay assay 
For mRNA decay experiments with Tet-off system, doxycycline (1 μg/ml) (Sigma) was 
added to the medium for the indicated time intervals before harvesting Tet-off 293 cells. 
Total RNA was isolated using Trizol (Invitrogen). mRNA levels were determined either 
by northern blot or by RT-qPCR analysis. For determining RNA decay using the 
Click-iT® Nascent RNA Capture Kit (Invitrogen), peritoneal macrophages were 
labelled with EU (0.5 mM) and stimulated with LPS (100 ng/mL) for 2 hr and the 
medium was replaced with growth medium without EU for the indicated time intervals 
before harvesting EU-labeled peritoneal macrophages. EU-labeled RNAs (EU-RNAs) 
were biotinylated and the biotinylated RNAs were purified with streptavidin magnetic 
beads and analyzed with RT-qPCR. 
 
Luciferase assay 
HeLa cells were transfected with luciferase reporter plasmid pGL3 containing the 3′ 
UTR of indicated genes, together with expression plasmid for Regnase-1 or empty 
(control) plasmid. After 24 h of cultivation, cells were lysed and luciferase activity in 
lysates was determined with the Dual-Luciferase Reporter Assay system (Promega). 
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Data are presented as means ± standard deviation. Statistical significance was calculated 
with a Student’s t-test. Significance was accepted at the level of P < 0.05 (*), P < 0.01 
(**) or P < 0.001 (***). 
 
Materials and experimental procedures are detailed in the Extended Experimental 
Procedures. 
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Figure Legends 
Figure 1. Identification of Reg1 target mRNAs 
(A) SHAPE analysis of in vitro synthesized Il6 3′UTR (84-103) RNA.  
(B and C) Schematic representation of Il6 3′UTR-(84-103) (B), and Il6 3′UTR and 
antisense morpholinos (C). 
(D) HeLa cells were transfected with the Il6 3′UTR reporter, antisense morpholinos, and 
Reg1 expression plasmids. The luciferase activities are shown as relative values. 
(E) Ctrl- and Il6-SL-MO were delivered into WT BMMs followed by stimulation with 
LPS. Cytokine mRNA (top) and protein (bottom) levels were analyzed by RT-qPCR and 
ELISA, respectively. 
(F) WT BMMs delivered with antisense morpholinos were i.p. transfused into Il6–/– 
mice (6-week-old, n = 4). The mice were i.p. injected with LPS (0.5 mg/kg of BW). 
Cytokine levels in sera were measured by ELISA 24 h after transfusion. 
(G) Schematic representation of N-BoxB tethering system. 
(H) Tef-off 293 cells were transfected with pTRE-Il6CDS-5XBoxB and indicated 
expression plasmids. Total RNAs were prepared after Dox treatment, and Il6 levels 
were determined by Northern blot analysis. 
(I) Immunoblot analysis of Reg1 in HeLa cells transfected with indicated expression 
plasmids. 
(J) Correlation of ppm between control IP samples (x axis) and Reg1 IP samples (y axis). 
mRNAs associated with Reg1 in IL-1-stimulated HeLa cells were determined by 
RIP-seq. 
(K) Luciferase activity of HeLa cells transfected with reporter plasmids expressing 
3′UTR of indicated genes and Reg1 expression plasmids. 
Unless otherwise indicated, Data are mean ± SD (n = 3). See also Figures S1 and Table 
S1 and S2. 
 
T. Mino et al.  
 28
Figure 2. Identification of the consensus sequences of the Reg1 target mRNAs and 
their overlap with Roquin 
(A and B) GSEA of overlap between Reg1 and Roquin target genes (RIP-seq based). ES 
plots are shown with genes ranked according to their Roquin (A) and Reg1 (B) RIP-seq 
p values. The right part shows the histogram for the max ES scores. 
(C, G, J, K) Luciferase activity of HeLa cells transfected with indicated reporter, Reg1 
and Roquin expression plasmids. Data are mean ± SD (n = 3). 
(D) Phosphorimages of NuPAGE gels that resolved 5′-[32P]-labelled RNA–Flag-Reg1 IP. 
Lower panels show immunoblots for Reg1. 
(E) Proportion of Reg1 binding sites obtained by the intersection of two biological 
HITS-CLIP replicates. 
(F) Schematic representation of TM2D3 (95-120). 
(H) SL enrichment in Reg1 bound CLIP tags in 3′UTRs compared to 1000 individual 
sequence permutations. The bar color represents the p value corresponding to the 
enrichment. 
(I) Description of significantly enriched Reg1 bound SLs harboring a hairpin of 3 
nucleotides with varying stem length (3, 5 or 7 nucleotides). Representation of SL 
sequence as Position Weight Matrix (PWM) logos. Logos are centered on the hairpin 
midpoint. Letter scale corresponds to relative nucleotide entropy. 
See also Figure S2 and S3, and Table S3 and S4. 
 
Figure 3. Reg1 localizes to ER and polysome fraction 
(A, B) NIH3T3 cells expressing Flag-Reg1 were treated with arsenite and analyzed by 
confocal fluorescence microscopy. 
(C) Immunoelectron microscopy showing the localization of Reg1 in NIH3T3 cells. The 
black arrows indicate Reg1 localized at surface of ER. Scale bar, 1 m. mt, 
mitochondria. 
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(D) Subcellular fractions of Reg1 prepared from NIH3T3 cells were analyzed by 
Immunoblotting. 
(E) The lysates from HeLa cells were fractionated by sucrose gradient. The expression 
of Reg1 and Roquin in the fractions was analyzed by Immunoblotting. 
(F–H) Quantification of RNAs of non-polysome and polysome fractions. The lysates 
from HeLa cells transfected with indicated siRNA and stimulated with IL-1 were 
fractionated by sucrose gradient (F) and RNAs from the fractions were analyzed by 
RT-qPCR for the expression of indicated mRNAs (G, H). Data are mean ± SD (n = 3). 
See also Figure S4. 
 
Figure 4. Translationally active mRNAs are targeted by Reg1 via the stop codon 
(A) WT and Reg1–/– macrophages were labelled with EU, stimulated with LPS and 
treated with anisomycin or CHX for 2 hr. EU-labeled Il6 and Ptgs2 mRNAs were 
captured by the Click-iT Nascent RNA Capture Kit and measured by RT-qPCR.  
(B and C) Tef-off 293 cells were co-transfected with pTRE-Il6 CDS-3′UTR and 
indicated expression plasmids. Cells were then treated with anisomycin or CHX, and 
RNAs were prepared after Dox treatment, and Il6 mRNA levels were determined by 
Northern blot analysis (B) and the autoradiographs were quantified (C). 
(D) Schematic representation of SSL-inserted mRNAs. 
(E) The SSL inhibited luciferase activity, but not its mRNA expression. 
(F and G) Degradation of Il6, SSL-inserted Il6 and stop codon-deleted (STOP) Il6 by 
Reg1 was measured as in (B) (F), and the autoradiographs were quantified (G). 
 (H) Luciferase activity of HeLa cells transfected with the Il6 reporter lacking a stop 
codon and Reg1 expression plasmids. 
(I and J) Schematic representation of deletion mutants of Il6 3’UTR (I). Degradation of 
Il6 mutant mRNAs was measured and quantified (J). 
Unless otherwise indicated, Data are mean ± SD (n = 3). 
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See also Figure S5. 
 
Figure 5. Reg1 interacts with Ribosome proteins and UPF1 
(A) Schematic representation of the iTRAQ workflow. 
(B) Proteins enriched by iTRAQ-based proteomics identifying Reg1-associated 
proteins. 
(C) Recombinant Reg1 co-precipitated with ribosome purified from HeLa cells was 
analyzed by SDS-PAGE. 
(D and F) Immunoblot analysis of UPF1 co-precipitated with Flag-Reg1-WT and 
D141N (D) or its deletion mutants (F) in HeLa cells. 
(E) Schematic representation of Reg1. 
(G) Luciferase activity of HeLa cells transfected with indicated reporter and Reg1 
mutant plasmids. Data are mean ± SD (n = 3). 
See also Table S5. 
 
Figure 6. UPF1 is essential for Reg1-mediated mRNA decay 
(A and B) Reg1-mediated degradation of Il6 was measured in UPF1 knockdown cells 
(A) and the autoradiographs were quantified (B). 
(C) Luciferase activity of HeLa cells transfected with UPF1, UPF2 or UPF3x siRNA, 
indicated reporter and Reg1 expression plasmids. 
(D) Luciferase activity of UPF1 knockdown HeLa cells transfected with indicated 
reporter and the Roquin-1 expression plasmid. 
(E) HeLa cells were transfected with the indicated siRNA and stimulated with IL-1. 
RNA expression profiles were analyzed by RT-qPCR. 
(F) Cells expressing Il6 were transfected with UPF1 siRNA and/or Flag-Reg1. Il6 
co-precipitated with Reg1 were analyzed by RT-qPCR. 
(G) Tethering Reg1 did not destabilize the luciferase-5BoxB under knockdown of UPF1. 
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Luciferase activity of UPF1 knockdown HeLa cells transfected with indicated reporter 
and expression plasmids. 
(H) Degradation of Il6CDS-5BoxB mRNA under treatment with anisomycin was 
measured and quantified. 
(I) Immunoblot analysis of UPF1 co-precipitated with Flag-Reg1 in HeLa cells under 
treatment with anisomycin. 
(J-L) HeLa cells transfected with UPF1 siRNA were reconstituted with siRNA-resistant 
HA-UPF1-WTR or HA-UPF1-DEAAR. Immunoblot analysis for the UPF1 
reconstitution (J). Luciferase activity of reconstituted cells, after transfection of 
indicated reporter and Reg1 expression plasmids (K). RNA expression profiles of 
reconstituted cells stimulated with IL-1 (L). 
Unless otherwise indicated, Data are mean ± SD (n = 3). See also Figure S6. 
 
Figure 7. Roles of Reg1 and Roquin in the control of inflammatory mRNAs in 
response to LPS 
(A-C) WT, Reg1–/– and Roquinsan/san BMMs were stimulated with LPS. RNA expression 
profiles were analyzed by RT-qPCR (A). Ptgs2 expression were analyzed by 
immunoblotting (B). The Protein/mRNA ratio of Ptgs2 is shown in (C). 
(D) WT, Reg1–/–; Roquinsan/san, Reg1–/– and Roquinsan/san MEFs were stimulated with LPS 
and RNA expression profiles were analyzed by RT-qPCR. 
(E) GSEA of overlap between Reg1 (left) or Roquin (right) target genes (RIP-seq based) 
and Reg1–/–; RoquinSan/San enrichment (transcriptome analysis based). An ES plot is 
shown with genes ranked according to their Reg1–/–; RoquinSan/San enrichment p value. 
(F) GSEA of overlap between Reg1 (left) or Roquin (right) target genes (RIP-seq based) 
and Reg1–/– enrichment (transcriptome analysis based). An ES plot is shown with genes 
ranked according to their Reg1–/– enrichment p value. 
(G) A proposed model of mRNA degradation by Reg1 and Roquin. 
T. Mino et al.  
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Q5D1E8 Zinc finger CCCH domain-containing protein 12A 
(ZC3H12A)
7.884 19.8
P07437 Tubulin beta chain (TUBB) 2.359 12.6
P62899 60S ribosomal protein L31(RPL31) 2.245 7.5
P46782 40S ribosomal protein S5 (RPS5) 1.825 13.5
P62701 40S ribosomal protein S4, X isoform (RPS4X) 1.741 6.8
P68104 Elongation factor 1-alpha 1 (EEF1A1) 1.724 10.8
P98175 RNA-binding protein 10 (RBM10) 1.635 1.3
P23246 Splicing factor, proline- and glutamine-rich (SFPQ) 1.534 0.7
P05387 60S acidic ribosomal protein P2 (RPLP2) 1.500 9.7
Q8NC51 Plasminogen activator inhibitor 1 RNA-binding protein 
(SERBP1)
1.413 18.8
P21333 Filamin-A (FLNA) 1.357 8.8
P63173 60S ribosomal protein L38 (RPL38) 1.341 12.4
P08708 40S ribosomal protein S17 (RPS17) 1.334 7.8
P55072 Transitional endoplasmic reticulum ATPase (VCP) 1.300 0.8
P24534 Elongation factor 1-beta (EEF1B2) 1.290 12.2
Q92900 UPF1 regulator of nonsense transcripts homolog 
(UPF1)
1.285 11.8
P35268 60S ribosomal protein L22 (RPL22) 1.270 4.4
P61978 Heterogeneous nuclear ribonucleoprotein K 
(HNRNPK)
1.262 4.3
Q9BUA3 Uncharacterized protein C11orf84 (C11orf84) 1.245 0.2
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Extended Experimental Procedures 
Mice 
Mice deficient in Reg1 have been described (Matsushita et al., 2009). Sanroque mice 
were kindly provided by Dr. Masakazu Hattori (Kyoto University). Il6–/– mice were 
kindly provided by Dr. Masao Matsuoka (Kyoto University). All animal experiments 
were done with the approval of the Animal Research Committee of the Institute for 
Virus Research, Kyoto University. 
 
Cell culture and transfection 
Primary MEFs were prepared from wild-type, Reg1–/–, Roquinsan/san or 
Reg1–/–/Roquinsan/san mouse embryos at embryonic day 13.5. Dicer-ablated MEFs were 
provided by Stephen N. Jones (Mudhasani et al., 2008). MEFs, NIH3T3 cells, RAW 
cells, HeLa cells and HEK293 cells were maintained in DMEM (Nacalai Tesque) 
supplemented with 10% (vol/vol) FBS and 50 μM -mercaptoethanol (Invitrogen). 
Tet-off HEK293 cells were purchased from Clontech and maintained in -MEM 
(Nacalai Tesque) supplemented with 10% (vol/vol) FBS (Clontech), 50 μM 
-mercaptoethanol and 100 g/mL G418 (Nacalai Tesque). Flp-In 293 T-REx cells 
(Invitrogen) were grown in DMEM high glucose with 10% (v/v) FBS and 2 mM 
L-glutamine. Cells were transfected through the use of Lipofectamine 2000, 
Lipofectamine 3000, Lipofectamine LTX (Invitrogen), the Neon transfection system 
(Invitrogen) or the Nucleofector system (Lonza) according to the manufacturer’s 
recommendations. 
 For siRNA-mediated knockdown, cells were transfected through the use of 
Lipofectamine RNAiMAX (Invitrogen), MISSION siRNA Transfection Reagent 
(Sigma) or the Neon transfection system (Invitrogen). The siRNAs used in this study 
were synthesized by Ambion and the following siRNA target sequences were used: 















 Peritoneal macrophages were prepared from mice 3 d after intraperitoneal 
injection of 4% (vol/vol) thioglycollate medium (2 ml) (Sigma) and were maintained in 
RPMI-1640 medium (Nacalai Tesque) supplemented with 10% (vol/vol) FBS and 50 
μM -mercaptoethanol. 
 For preparation of bone marrow–derived macrophages (BMMs), bone marrow 
cells were isolated from wild-type, Reg1–/–, or Roquinsan/san mice and cultured in 
macrophage growth medium (RPMI-1640 medium supplemented with 10% (vol/vol) 
FBS, 50 μM β-mercaptoethanol, 100 U/ml of penicillin, 100 μg/ml of streptomycin and 
20 ng/ml of macrophage colony-stimulating factor). After 5 days, cells were washed 
once and cultivated for 2 days with macrophage growth medium, then cells were 
collected for further analysis. 
 
Plasmid construction and reagents 
The cDNAs of mouse Reg1 (Zc3h12a), the D141N mutant and mouse Il6 have been 
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described (Matsushita et al., 2009). The cDNAs of Reg1 were ligated to the vector 
pFlag-CMV2 (SIGMA) and pcDNA3.1(+) (Invitrogen) for mammalian expression, 
pMRX-ires-puro (Cell Biolabs) for retrovirus production, pGEX-6P1 (GE Healthcare) 
for E. coli expression and pTNT vector (Promega) for protein production. The cDNAs 
of Il6 CDS-3′ UTR and -globin CDS-Reg1 3′ UTR were inserted in pTREtight vector 
(Clontech). The 3′ UTR cDNAs of Il6 were inserted downstream of the T7 promoter of 
pBluescript II KS (–) (Stratagene). The 3′ UTR cDNAs of a set of genes were inserted 
in the pGL3-promoter (Promega). pENTR4 constructs were generated by PCR 
amplification of the Reg1 coding sequences (CDS) from cDNA followed by restriction 
digest and ligation into the pENTR4 (Invitrogen) backbone, which were further 
recombined into the pFRT/TO/FLAG/HA-DEST destination vector (Baltz et al., 2012) 
using GATEWAY LR recombinase (Invitrogen) according to manufacturer's protocol. 
 TOPuro-hCaf1a-AA-mycSG, pcDNA3-Flag-hDcp2-AA, 
pLNCX2-EGFP-mRoquin, and pCI-neo-Flag-mRoquin were kindly provided by Georg 
Stoecklin (German Cancer Research Center). pSR-myc-hUPF1-WT, siRNA-resistant 
pSR-HA-hUPF1-WT(R) and pSR-HA-hUPF1-D648A/E649A (DEAA) (R) were kindly 
provided by Akio Yamashita (Yokohama City University).  
LPS from Salmonella minnesota and puromycin were from Invivogen. 
Recombinant cytokines were from R&D Systems. Anisomycin, cycloheximide and 
actinomycin D were from Sigma; Harringtonine was from LKT Laboratories. 
 
In vitro RNA cleavage assay 
In vitro RNA cleavage assay has been previously described (Matsushita et al., 2009). 
Briefly, Recombinant Reg1 protein (Matsushita et al., 2009) and in vitro transcribed 
5′-[32P]-labelled RNAs were mixed in cleavage buffer (25 mM HEPES, 50 mM 
potassium acetate, 5 mM DTT, 5 mM magnesium acetate and 0.2 U/ml RNasin 
(Promega)). The cleaved RNA was purified with Trizol (Invitrogen) and analysed by 
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denaturing 6% polyacrylamide-TBE-urea gels (Invitrogen) and autoradiography. 
 For generation of the circular RNA, in vitro transcribed 5′-[32P]-labelled mIl6 
3′ UTR (1-403) RNA was circularised by T4 RNA Ligase 1 (ssRNA Ligase) (NEB) in 
ligation buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 10% PEG8000, 50 
M ATP and 0.2 U/ml RNasin (Promega)) at 25ºC for 2 h. The RNA product was 
subjected to in vitro RNA cleavage assay as described above. 
 
RNA motif exploring by selective 2′-hydroxyl acylation analyzed by primer 
extension (SHAPE) chemistry and computational analysis 
RNA SHAPE chemistry has been described (Wilkinson et al., 2006). Briefly, DNA 
templates for mIl6 3′ UTR (84-103), mPtgs2 3′ UTR (1204-1237) or stem-loop structure 
were inserted in the context of flanking 5′ and 3′ structure cassette (Wilkinson et al., 
2006), which was inserted downstream of the T7 promoter of pBluescript II KS (–) 
(Stratagene), and in vitro transcribed by T7 RNA polymerase (MEGAscript T7 
Transcription Kit, Invitrogen). The in vitro transcribed RNAs were refolded in RNA 
folding buffer (100 mM Tris-HCl, pH 8.0, 100 mM NaCl and 6 mM MgCl2) in a final 
volume of 18 l. After folding, RNAs were modified in the presence of 6.5 mM 
N-methylisatoic anhydride (NMIA) (M-25; Invitrogen) and incubated at 20ºC for 4 h. 
After modification, RNAs were subjected to reverse transcription (ReverTra Ace, 
Toyobo) using a 5′-[32P]-labelled DNA primer (5′-GAACCGGACCGAAGCCCG-3′) 
specific to the 3′ structure cassette. For G or A sequencing experiment, primer 
extensions were performed in the presence of cytosine or thymidine dideoxy 
terminating nucleotides, respectively. The cDNA fragments are resolved on denaturing 
8% polyacrylamide-TBE-urea sequencing gels followed by autoradiography. 
Computational prediction of the RNA secondary structures was performed using the 
RNAfold from the Vienna package (Lorenz et al., 2011).  
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Tethered Function Assays 
Reg1 was artificially recruited to reporter mRNAs by the BoxB-N-peptide tethering 
system (Mishima et al., 2012). The 22 amino acid RNA-binding domain ofN peptide 
was fused with the N terminus of Reg1 and five 19 nt N binding sequences (5XBoxB) 
were tandemly inserted in a downstream of Il6 coding sequence (CDS) or luciferase 
CDS. Tet-off 293 cells and HeLa cells were transfected with the 5XBoxB reporter 
plasmids, together with expression plasmid for Flag-N-Reg1 or empty (control) 
plasmid followed by luciferase assay, mRNA decay assay and RNA IP. 
 
RNA immunoprecipitations (RIP)-sequencing analysis 
RNA immunoprecipitation was performed using a RIP-Assay Kit (RN1001; Medical & 
Biological Laboratories) according to the manufacturer's protocol with some 
modifications. Briefly, HeLa cells were transfected with expression vector for 
Flag-tagged Reg1-D141N mutant, Roquin-1 or empty (control) vector and stimulated 
with IL-1 (10 ng/mL) for 0 or 2 h. RNA-protein complexes from lysate of HeLa cells 
were immunoprecipitated with anti-Flag antibody (F3165; Sigma) bound to protein G 
magnetic beads and RNAs were extracted from the beads. The quality of RNA was 
analyzed by the Bioanalyzer Nano 6000 chip (Agilent Technologies). Only samples 
with an RNA Integrity Number (RIN) greater than 9.0 were used for further experiments. 
RNA library was prepared using Small RNA Sample Prep kit v1.0 (Illumina Inc.) and 
sequenced on a HiSeq 2000 system (Illumina) also according to the manufacturer's 
instructions. Fourteen and 0.6 million RNA reads were obtained for Reg1 and 16.1 
million for control. The resulting set of trimmed reads were then mapped against the 
human genome (hg19; NCBI). Analysis of enrichment of mapped reads in the Reg1 RIP 
samples vs control IP samples was performed using the R package DESeq (Anders and 
Huber, 2010), as follows. The count of mapped reads to each gene was used as input for 
the method. The coverage of each sample and the dispersions were estimated from the 
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read count data using the functions provided in the package. Finally, differential tag 
counts for each gene between the RIP and control sample for each of the two time 
points were estimated based on the negative binomial distribution. Genes with an 
unadjusted p value for enrichment in the RIP samples ≤ 1e-3 were regarded as candidate 
Reg1 targets. 
 
Analysis of overlap with between Reg1 targets and Roquin targets. 
The overlap between the targets of Reg1 and those of Roquin was evaluated using three 
measures. First, we employed the Gene Set Enrichment Analysis (GSEA) methodology, 
as described (Subramanian et al., 2005). In this case, we defined a set of genes S as the 
Reg1 targets based on their enrichment in RIP-seq samples at 0h, 2h, and both time 
points combined. On the other hand, a ranked list L was obtained by sorting the 
genome-wide set of genes by their enrichment in the Roquin RIP-seq samples of the 
same time points. The distribution of S in L was evaluated by calculating an Enrichment 
Score (ES) and the estimation of a significance level for ES by 10,000 random 
permutations, as described (Subramanian et al., 2005). The P value of enrichment of S 
in the top of L was estimated as the fraction of permuted samples resulting in a higher 
ES than the actual data. 
The statistical significance of overlap between Reg1 targets and Roquin targets was also 
evaluated using the Kolmogorov-Smirnov statistical test, which is closely related to the 
GSEA approach, and the hypergeometric distribution. In the latter case, Roquin targets 
were defined as the 52 genes having a p value of enrichment in the RIP sample smaller 
than 0.01 at either of the time points, and Reg1 targets as 68 genes having a p value of 
enrichment < 0.001 at either of the time points. The number of overlapping targets of 
both time points were compared to the expected number according to the 
hypergeometric distribution. Both the Kolmogorov-Smirnov and the hypergeometric 
test were performed using the R language. Candidate mouse Roquin targets were 
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obtained from (Leppek et al., 2013). The 92 human homologs of the mouse targets were 
defined using human-mouse homology data as available from the Mouse Genome 
Database (MGD) at the Mouse Genome Informatics website, The Jackson Laboratory 
(http://www.informatics.jax.org; April 2014). 
 
Generation of NIH3T3 cells stably expressing Flag-tagged Reg1 
NIH3T3 cells were transduced with retroviral supernatant for 12 h. Retroviral 
supernatants were produced by PlatE packaging cells (Cell Biolabs) transfected with 
retroviral expression vectors. Supernatants were collected 48 h after transfection, were 
filtered through 0.22-μm filters and were used for infection. After transduction, cells 
were washed and resuspended for 12 h in maintenance media. Cells were washed once 
and cultured in maintenance media with 2 μg/ml puromycin. Stable clones were 
obtained by selection in the presence of puromycin (2 μg/mL) and analyzed by Western 




For immunofluorescence staining, NIH3T3 cells stably-expressing Flag-tagged Reg1 
were used because of large cell cytoplasm in this cell type. In addition, HeLa cells 
transiently-expressing Flag-tagged Reg1 were also used. The cells were fixed in 3% 
paraformaldehyde in PBS for 15 min, incubated with 50 mM NH4Cl in PBS for 10 min, 
permeabilized in 0.5% Triton X-100 and 0.1% gelatin in PBS for 10 min, washed three 
times in 0.1% gelatin in PBS and blocked in 0.1% gelatin and 2% goat-serum (X0907; 
Dako) in PBS for 30 min at room temperature. Primary antibodies to Flag (F3165 or 
F7425; Sigma), /-Tubulin (#2148; Cell Signaling Technology), Calnexin (ab22595; 
Abcam), PDI (#3501; Cell Signaling Technology), RPL7A (15340-1-AP; Proteintech 
Group), Dcp1a (ab47811; Abcam) or TIA1 (ab40693; Abcam) were used for staining in 
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combination with secondary antibodies conjugated to Alexa 488 (A11017 or A11070; 
Invitrogen) or Alexa 568 (A11019 or A21069; Invitrogen). Images were captured on a 
Leica TCS SPE confocal microscopes (Leica) and an All-in-one Type Fluorescence 
Microscope (BZ-9000; Keyence) and analyzed with the LAS-AF software (Leica) and 
BZ Analyzer Software (Keyence), respectively. 
 For RNA fluorescence in situ hybridization (RNA FISH) combined with 
immunofluorescence (IF) staining, HeLa cells were stimulated with IL-1 (10 ng/ml) 
for 4 h and were subjected to RNA FISH. RNA FISH was performed using the 
RNAscope Multiplex Fluorescent Assay (Advanced Cell Diagnostics) according to the 
manufacturer's protocol with some modifications. Briefly, cells were fixed in 4% 
paraformaldehyde in PBS for 20 min, serially dehydrated and rehydrated for 5 min each 
in graded alcohol (50%, 70% and 100% EtOH), treated with protease for 10 min at 
room temperature and hybridized with RNAscope probes at 40°C. After the washing 
step, cells were blocked in 1% (wt/vol) Blocking Reagent (11096176001; Roche) in 
PBS for 1 h at room temperature. Primary antibodies to Dcp1a (ab47811; Abcam) were 
used for staining in combination with secondary antibodies conjugated to Alexa 568 
(A21069; Invitrogen). Images were captured on a Leica TCS SPE confocal microscopes 
(Leica) and analyzed with the LAS-AF software (Leica). 
 
Immunoelectron microscopy 
Immunoelectron microscopy has been described (Matsunaga et al., 2009). Briefly, 
NIH3T3 cells stably-expressing Flag-tagged Reg1 were fixed with 4% 
paraformaldehyde for 30 min in 0.1 M sodium-phosphate buffer (pH 7.4) and washed 
for 5 min three times in the sodium-phosphate buffer. Cells were permeabilized and 
blocked for 30 min with 0.2% saponin, 10% BSA, 10% normal goat serum and 0.1% 
cold-water fish gelatin in the sodium-phosphate buffer. Cells were stained with anti-Flag 
mouse monoclonal antibody (F3165; Sigma) overnight at 4°C, washed for 10 min six 
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times in the sodium-phosphate buffer containing 0.1% saponin, then stained for 2 h at 
room temperature with an anti-mouse IgG conjugated to 1.4 nm gold particle (Nanogold 
Fab′ fragment of goat anti-mouse IgG) (2002; Nanoprobes), washing for 10 min five 
times in the sodium-phosphate buffer containing 0.1% saponin. Electron micrographs 
were obtained with a JEM-1011 transmission electron microscope (JEOL). 
 
iTRAQ labeling and mass spectrometry 
iTRAQ labeling was performed using an iTRAQ reagent kit (Applied Biosystems) 
according to the manufacturer's protocol with some modifications. Briefly, cell lysates 
from RAW cells stably expressing Flag-tagged Reg1 and HeLa cells 
transiently-expressing Flag-tagged Reg1 together with their controls (Empty) were 
immunoprecipitated with anti-Flag Ab in the presence of Benzonase (50 U/mL) 
(Novagen). The immunoprecipitaed proteins (5 g each) were reduced, alkylated, 
digested, labeled with iTRAQ reagents and cleaned up with a cation exchange 
chromatography according to the manufacturer's (Applied Biosystems) protocol with 
some modifications. Control or Reg1 immunoprecipitates was labeled with iTRAQ 
Reagent 114 or 117, respectively. The iTRAQ reagent-labeled sample was analyzed by 
LC-MS/MS (Orbitrap LC-MS; Thermo Fisher Scientific). Proteins were identified by 
database searching using Mascot Daemon (Matrix Science). Based on an 80% 
confidence level (< 20% 117/114 variability), cutoff values of 1.2-fold for up-regulated 
proteins were used to define candidate proteins as Reg1-associated proteins. 
 
Sucrose gradient centrifugation (polysome profiles) 
HeLa cells were lysed in polysome buffer (20 mM HEPES-KOH [pH 7.5], 100 mM 
KCl, 5 mM MgCl2, 0.25% (vol/vol) Nonidet P-40, 10 g/ml cycloheximide, 100 
units/ml RNase inhibitor, protease inhibitor cocktail). Lysates were loaded on top of a 
linear 15%–60% sucrose gradient (15%–60% sucrose, 20 mM HEPES-KOH [pH 7.5], 
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100 mM KCl, 5 mM MgCl2, 10 g/ml cycloheximide, 100 units/ml RNase inhibitor, 
protease inhibitor cocktail). After ultracentrifugation at 38,000 rpm for 2.5 h at 4ºC in a 
HITACHI P40ST rotor, fractions were collected from the top of the gradient and 
subjected to UV-densitometric analysis. The absorbance profiles of the gradients were 
determined at 254 nm. For disassociation of ribosome and polysome, EDTA was added 
to Mg2+-free polysome buffer and 15%–60% sucrose gradient at concentrations of 50 
mM and 20 mM, respectively. For protein analysis, each fraction was subjected to TCA 
precipitation and SDS-PAGE. Immunoblotting was performed using the indicated 
antibodies. For RNA analysis, each fraction was subjected to High Pure RNA Isolation 
Kit (Roche) and RT-qPCR. 
 
Immunoblot analysis 
Whole-cell extracts were prepared in lysis buffer (1% (vol/vol) Nonidet P-40, 0.1% 
(wt/vol) SDS, 1% (wt/vol) sodium deoxycholate, 150 mM NaCl, 20 mM Tris-HCl, pH 
8.0, 10 mM EDTA and Complete Mini Protease Inhibitor Cocktail without EDTA 
(Roche)). The following antibodies were used for immunoblot analysis: antibody to 
Flag (F3165 and F7425; Sigma), c-Myc (M4439 and C3956; Sigma), /-Tubulin 
(#2148; Cell Signaling Technology), Calnexin (ab22595; Abcam), PDI (#3501; Cell 
Signaling Technology), Roquin-1 (A300-514A; Bethyl Laboratories, Inc.), Roquin-2 
(ab99090; Abcam), Staufen1 (STAU1) (A303-956A; Bethyl Laboratories, Inc.), UPF2 
(ab153830; Abcam), UPF3 (ab83249; Abcam), Dcp1a (ab47811; Abcam), TIA1 
(ab40693; Abcam), RPL7A (15340-1-AP; Proteintech Group), RPS4X (14799-1-AP; 
Proteintech Group), RPL7 (ab72550; Abcam), Ptgs2 (ab15191; Abcam) and -actin 
(sc-1615; Santa Cruz). Rabbit UPF1 antibody was kindly provided by Akio Yamashita 
(Yokohama City University). Rabbit Reg1 antibody has been described (Iwasaki et al., 
2011). Luminescence was detected with a luminescent image analyzer (ImageQuant 




Subcellular fractionation was performed using an Endoplasmic Reticulum Isolation Kit 
(Sigma) following the manufacturer’s instructions. Briefly, NIH3T3 cells were suspend 
in hypotonic extraction buffer (10 mM HEPES, pH 7.8, 25 mM potassium chloride and 
1 mM EGTA) to allow the cells to swell. Cells were adjusted to isotonic conditions by 
the addition of isotonic extraction buffer (10 mM HEPES, pH 7.8, 250 mM sucrose, 25 
mM potassium chloride and 1 mM EGTA) and homogenized by the Dounce 
homogenizer. The total lysate was centrifuged at 1,000 x g for 10 min at 4ºC, yielding a 
pellet consisting mainly of nuclei and unbroken cells. The supernatant was centrifuged 
at 12,000 x g for 15 min at 4ºC, yielding a pellet consisting mainly of mitochondria. The 
supernatant was ultracentrifuged at 100,000 x g for 1 h at 4ºC, yielding a pellet 
consisting mainly of microsomal fraction (cellular membranes, SER and RER). The 
supernatant from this 100,000 x g spin consists mostly of cytosol. The pellet consisting 
of microsomal fraction was resuspended in the isotonic extraction buffer and applied to 
an Optiprep gradient and ultracentrifuged at 150,000 x g for 3 h at 4ºC to obtain SER 
and RER fractions. Each fraction was collected and analyzed by Western blot with the 
indicated antibodies. 
 
Recombinant Reg1 proteins 
Flag-tagged Reg1 protein and its mutant protein were translated in vitro in the presence 
of [35S]-methionine with the TNT-coupled reticulocyte lysate system (Promega) 
following the manufacturer’s instructions with some modifications. After in vitro 
translation, lysates were treated with Benzonase (Novagen) and [35S]-labeled proteins 
were affinity purified using anti-Flag antibody affinity resin (Sigma) and eluted with a 3 





Ribosomes were purified from HeLa cells by sedimentation through a sucrose cushion 
(Zinzalla et al., 2011). Recombinant [35S]-radioactive Reg1 protein was incubated in 
ribosome binding buffer (10 mM Tris-HCl, pH 7.6, 100 mM KCl, 10 mM MgCl2, 1 mM 
DTT, 0.1 mg/mL BSA) for 30 min at 4ºC in the simultaneous absence or presence of the 
highly-purified ribosome (5 g). Subsequently the mixture was loaded on a 10% 
sucrose cushion (10 mM Tris-HCl, pH 7.6, 100 mM KCl, 10 mM MgCl2, 10% (wt/vol) 
Sucrose) and ultracentrifuged for 20 min at 300,000 x g at 4ºC to pellet the ribosome 
and ribosome-associated protein. The pellets were analyzed by SDS-PAGE and 
quantitative autoradiography. 
 
Quantitative PCR analysis 
Total RNA was isolated using ISOGEN II (Wako) or Trizol (Invitrogen) and 
reverse-transcribed using ReverTra Ace (Toyobo) or MicroRNA RT Kit (Applied 
Biosystems) according to the manufacturer’s instructions. For quantitative PCR, cDNA 
fragments were amplified through the use of Thunderbird Probe qPCR Mix (Toyobo) or 
TaqMan® MicroRNA Assays (Applied Biosystems); TaqMan probes for mouse Il6, 
mouse -Actin, mouse 18S rRNA, human IL6, human 18S rRNA and human -ACTIN 
were from Applied Biosystems. Fluorescence was detected with a StepOne Real-Time 
PCR System (Applied Biosystems). For analysis of the induction mRNA in response to 
LPS stimulation, the abundance of mRNA of each expressed gene was normalized to 
that of 18S rRNA or β-Actin. 
 
Protein IP 
HeLa cells and Tet-off 293 cells transiently-expressing Flag-tagged Reg1 and RAW 
cells and Jurkat cells stably-expressing Flag-tagged Reg1 were lysed in lysis buffer 
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(0.5% (vol/vol) Nonidet P-40, 150 mM NaCl, 10 mM Tris-HCl, pH 8.0 and Complete 
Mini Protease Inhibitor Cocktail without EDTA (Roche)). Anti-Flag antibody (F3165; 
Sigma) bound to protein G magnetic beads (Invitrogen) was incubated for 3 h at 4ºC 
with lysates. Beads were washed three times with lysis buffer and suspended in SDS 
sample buffer (50 mM Tris-HCl, pH 6.8, 2% (wt/vol) SDS, 5% (vol/vol) 
β-mercaptoethanol, 10% (vol/vol) glycerol and bromophenol blue). Samples were 
boiled for 5 min at 95°C and analyzed by Western blot with the indicated antibodies. 
 
RNA IP 
HeLa cells and Tet-off 293T cells transfected with the indicated siRNA and expression 
plasmids and RAW cells stably expressing Flag-tagged Reg1 were lysed in RNA IP 
lysis buffer (0.5% (vol/vol) Nonidet P-40, 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 
Complete Mini Protease Inhibitor Cocktail without EDTA (Roche) and 0.2 U/ml RNasin 
(Promega)). Anti-Flag antibody (F3165; Sigma) bound to protein G magnetic beads 
(Invitrogen) was incubated for 3 h at 4ºC with lysates and beads were washed three 
times with RNA IP lysis buffer. RNAs were eluted from the beads using Trizol reagent 
(Invitrogen) according to the manufacturer’s instructions and analyzed by RT-qPCR. 
Proteins were eluted from the beads using SDS sample buffer (50 mM Tris-HCl, pH 6.8, 
2% (wt/vol) SDS, 5% (vol/vol) β-mercaptoethanol, 10% (vol/vol) glycerol and 
bromophenol blue) and analyzed by Western blot with the indicated antibodies. 
 
Morpholino delivery and ELISA for sera and culture supernatants 
The antisense morpholino oligonucleotides used in this study were synthesized by Gene 
Tools, LLC and the following 25-mer morpholinos were used: Il6-SL-MO, 
5′-CATTCATATTGTCAGTTCTTCGTAG-3′; and Ctrl-MO as the standard control 
oligo from Gene Tools, LLC (SC100), 5′-CCTCTTACCTCAGTTACAATTTATA-3′. 
For delivery of antisense morpholino oligonucleotides to HeLa cells or bone marrow 
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macrophages (BMMs) from wild-type mice, morpholinos were added to the medium at 
a final concentration of 2 M in the presence of 6 M Endo-Porter (Gene Tools, LLC) 
according to the manufacturer’s protocol, and cells were incubated for 24 h and used in 
subsequent experiments. HeLa cells were used in luciferase assay as described above. 
 For measurement of Il6 and Tnf concentrations in culture supernatants from 
BMMs, BMMs were stimulated with LPS (100 ng/mL) and cytokine levels in culture 
supernatants were measured by cytokine-specific ELISA kits (R&D systems) following 
manufacturer’s protocols. Cytokine mRNA levels in BMMs were analyzed by RT-qPCR 
as described above. 
 For measurement of Il6 and Tnf concentrations in sera from Il6–/– mice, BMMs 
(5 x 106 cells) were intraperitoneally (i.p.) transfused into Il6–/– mice (6-week-old, n = 4). 
The mice were injected with LPS (0.5 mg/kg of body weight, i.p.) 24 h after transfusion, 
and cytokine levels in sera were measured by cytokine-specific ELISA kits (R&D 
systems) following manufacturer’s protocols. 
 
HITS-CLIP 
Flp-In 293 T-REx cell lines stably expressing FLAG/HA-tagged Reg1 protein were 
generated by co-transfection of pFRT/TO/FLAG/HA constructs with pOG44 
(Invitrogen). Cells were selected by adding 15 µg/ml blasticidin and 100 µg/ml 
hygromycin (Invivogen). Expression of epitope-tagged proteins was induced by 
addition of 1 µg/ml doxycyclin. The expression of FLAG/HA tagged Reg1 protein was 
assessed by Western analysis using mouse anti-HA.11 monoclonal antibody (Covance). 
HITS-CLIP was performed essentially as described (Hafner et al., 2010). Briefly, 
UV-irradiated cells were lysed in NP-40 lysis buffer (50 mM HEPES-KOH at pH 7.4, 
150 mM KCl, 2 mM EDTA, 0.5% (v/v) NP40, 0.5 mM DTT, complete EDTA-free 
protease inhibitor cocktail). After treatment with RNaseT1 (Fermentas) at final 
concentration of 0.5 unit/l, immunoprecipitation was carried out with Flag magnetic 
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beads (SIGMA) from HEK293 cell extracts for 1 h at 4ºC. Following additional 
digestion by RNase T1 (Fermentas) at final concentration of 0.5 unit/l, beads were 
incubated with calf intestinal phosphatase (NEB) and RNA fragments were 
radioactively end-labeled using T4 polynucleotide kinase (Fermentas). The crosslinked 
protein-RNA complexes were resolved on a 4-12% NuPAGE gel (Invitrogen). The 
SDS-PAGE gel was transferred to a nitrocellulose membrane (Whatman) and the 
protein-RNA complex migrating at an expected molecular weight was excised. RNA 
was isolated by Proteinase K (Roche) treatment and phenol-chloroform extraction, 
ligated to 3′ adapter and 5′ adapter, reverse transcribed and PCR-amplified. The 
amplified cDNA was sequenced on a HighSeq2000 (Illumina) with a 1x51 nt cycle. 
 
Reg1 CLIP library processing 
Reads from the Reg1 CLIP library were stripped of the adaptor sequence stepwise using 
Cutadapt, keeping the randomized nucleotides (Martin, 2011) (3′ Adapter, 
NN-TGGAATTCTCGGGTGCCAAGG; 5′ Adapter, 
GTTCAGAGTTCTACAGTCCGACGATC-NN). Reads that were less than 24 
nucleotides in length or contained an ambiguous nucleotide were discarded. Reads were 
collapsed and then the randomized adapter nucleotides were trimmed using Flexbar 
(Dodt et al., 2012). The remaining reads were aligned to the human genome (hg19), 
with up to one mismatch allowed and ten alignment locations, with Bowtie version 
0.12.7 (Langmead et al., 2009). Grouping of the reads was done using PARalyzer 
(Corcoran et al., 2011) to retain only those that mapped to a single genomic location for 
the minimum number of mismatches. Unique reads were grouped with a minimum of 
one nucleotide of overlap. Annotation of the resulting groups was performed as 
described (Ascano et al., 2012). The two libraries were intersected on group level with 
at least one nucleotide overlap. Full group level data are provided in Table S4. 
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Stem loop enrichment and stem loop sequence analyses 
Group sequences were globally folded using RNAfold from the Vienna package 
(Lorenz et al., 2011) with default setting. Resulting stem loops have been quantified and 
compared against the number of retrieved stem loops after 1000 individual dinucleotide 
shuffles (using Dishuffle (Clote et al., 2005)) of the corresponding group sequences. 
Stem loop Postion weight matrixes were obtained using the web tool enoLOGOS 
(Workman et al., 2005), using stem loop sequences as input. RNA secondary structure 
and sequence motifs were predicted using Predict Motif (Rabani et al., 2008), using the 
entire Reg1 bound group sequence for the corresponding stem loop as input. 
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Supplemental Figure Legends 
Figure S1. Identification of novel Reg1 target molecules, related to Figure 1 
(A) Reg1 endonucleolytically cleaved the Il6 3′UTR (1-403) in vitro cleavage assay. 
Indicated circular or linear Il6 3′UTR RNAs were incubated with increasing amounts of 
recombinant Reg1 proteins. 
(B) Coomassie Brilliant Blue-stained SDS gel showing purified recombinant WT or 
D141N mutant Reg1 proteins.  
(C) Reg1 cleaved the (84-103) SL of Il6-3′UTR in vitro cleavage assay. Indicated Il6 
RNAs were incubated with increasing amounts of recombinant Reg1 proteins. 
(D) Luciferase activity of HeLa cells transfected with reporter plasmids expressing 
5XBoxB and Il6 3′UTR, together with indicated expression plasmids. The gene 
encoding Renilla luciferase was transfected simultaneously as an internal control. Data 
are mean ± SD. 
(E) MEFs from Reg1–/– and WT mice were stimulated with LPS (100 ng/mL) and 
miRNA expression levels were analyzed by RT-qPCR. Data are mean ± SD (n = 3). 
(F) Structural models of WT and D141N mutant Reg1 PIN domains. Cartoon 
representations of homology models of the PIN domain (residues 132-295) of WT and 
D141N mouse Reg1 after 10 ns of explicit water MD. Regions colored red are predicted 
to interact with RNA. 
(G) Luciferase activity of HeLa cells transfected with indicated reporter and indicated 
Roquin expression plasmids. Roquin-NT is an N-terminal fragment (amino acids [aa] 
2–441), which is responsible for RNA-binding. Data are mean ± SD. 
 
Figure S2. Identification of Reg1-recognition motives, related to Figure 1 
(A, D, E, I) Luciferase activity of HeLa cells transfected with indicated reporter and 
expression plasmids. Data are mean ± SD. 
(B, H) Schematic representation of Reg1-recognition sequences in mouse Nfkbiz (B) 
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and Ptgs2 (H) together with an alignment of 5 mammalian sequences. 
(C, F, J,) Schematic representation of Reg1-recognition stem-loop structures in Nfkbiz 
(C), Ptgs2 (F), TNE-CDE (J). 
(G) SHAPE analysis of in vitro synthesized mPtgs2 3′UTR (1204-1237) RNA. 
 
Figure S3. Reg1 recognizes stem-loop motifs in 3′UTRs, related to Figure 2 
(A, B) Schematic representation of TNF-CDE (A) and an artificial stem-loop (B) 
structures. 
(C) SHAPE analysis of in vitro synthesized a “UAU-loop” stem-loop RNA. 
(D, E) Luciferase activity of HeLa cells transfected with indicated reporter and Reg1 
expression plasmids. Data are mean ± SD. 
(F–H) mRNAs associated with Reg1 in HeLa cells transfected with indicated expression 
plasmids were recovered by RNA IP and analyzed RT-qPCR. Data are mean ± SD. 
Lower panels show immunoblots probed with an anti-Flag antibody. 
 
Figure S4. Reg1 and Roquin degrade mRNAs via distinct mechanisms, related to 
Figure 3 
(A) Top: Degradation of Il6CDS-3′UTR mRNA under co-transfection with Caf1a-AA or 
Dcp2-AA was measured as in Figure 4B. Bottom: Quantification of the autoradiographs. 
Data are mean ± SD. 
(B and C) Immunofluorescent microscopy showing the localization of Roquin to PB 
and SG. NIH3T3 (B) and HeLa (C) cells transiently-expressing EGFP-tagged Roquin 
were treated with arsenite  for 1 h and analyzed by confocal fluorescence microscopy. 
(D) Immunoblot analysis of endogenous and Flag-Reg1 expression in Flag-Reg1 stably 
expressing NIH3T3 cells. The levels of Reg1 detected by ant-Reg1 Ab was quantified 
and shown. 
(E) Immunofluorescent microscopy showing the localization of Reg1 to the cytoplasm 
 21
and ER, but not to PB and SG. HeLa cells transiently-expressing Flag-Reg1 were 
analyzed by confocal fluorescence microscopy. 
(F) Fluorescence in situ hybridization of Ptgs2 and fluorescence immunostaining of 
Dcp1a (PB marker) in HeLa cells transfected with siRNA specific for Reg1 or 
Roquin-1/2 and stimulated with IL-1 for 4 h.  
(G) Quantification of Ptgs2 mRNAs in Figure S4F. Data are mean ± SD. 
(H) Quantification of Ptgs2 mRNAs localized in PB (%) in Figure S4F. Data are mean ± 
SD. 
 
Figure S5. Treatments with protein synthesis inhibitors have no effect on the 
localization of Reg1, related to Figure 4 
(A) NIH3T3 cells expressing Flag-Reg1 were treated with anisomycin or CHX for 2 h 
and analyzed by confocal fluorescence microscopy. 
(B) Immunoblot analysis of Reg1 transiently-expressed in Tet-off 293 cells under 
treatment with anisomycin or CHX as in Figure 4B and 4C. 
(C) IRES-dependent translation initiation had no effect on Reg1-mediated RNA decay. 
Degradation of IRES-Il6 mRNA was inserted in upstream of Il6 CDS, was measured as 
in Figure 4B. 
(D) Quantification of the autoradiographs in Figure S5C. Data are mean ± SD. 
 
Figure S6. Essential roles of UPF1 in Reg1-mediated mRNA decay, related to 
Figure 6. 
(A) Immunoblot analysis of UPF1 and Reg1 in RAW264.7 macrophages transfected 
with indicated siRNAs. 
(B) Luciferase activity of RAW264.7 macrophages transfected with indicated siRNA, 
reporter and Reg1 expression plasmids. Data are mean ± SD. 
(C) Luciferase activity of RAW264.7 macrophages transfected with indicated siRNA, 
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reporter and Roquin expression plasmids. Data are mean ± SD. 
(D) RAW264.7 macrophages were transfected with the indicated siRNAs and 
stimulated with LPS. RNA expression profiles were analyzed by RT-qPCR. Data are 
mean ± SD. 
(E) Immunoblot analysis of Reg1 in HeLa cells transfected with indicated expression 
plasmids. 
(F) mRNAs associated with Reg1 in Tet-off 293 cells treated with anisomycin were 
recovered by RNA IP and analyzed RT-qPCR. Data are mean ± SD. 
(G) Immunoblot analysis of UPF1 and its helicase dead mutant (DEAA) 
co-immunoprecipitated with Flag-Reg1-WT transiently-expressed in HeLa cells. 
 
Figure S7. Inflammatory gene expression in cells defective in the Reg1 and Roquin 
to TNF stimulation, related to Figure 7 
(A) HeLe cells transiently-expressing Flag-Reg1-D141N were analyzed by confocal 
fluorescence microscopy. 
(B) Luciferase activity of HeLa cells transfected with indicated reporter and Reg1 and 
Roquin expression plasmids. Data are mean ± SD. 
(C) The ratio of non-polysome and polysome RNA to total RNA in Figure 3H.  
(D) MEFs from Reg1–/–; Roquinsan/san, Reg1–/–, Roquinsan/san or WT mice were stimulated 
with TNF (10 ng/mL) and RNA expression profiles were analyzed by RT-qPCR. Data 
are mean ± SD. 
(E) Heat map of the expression of selected LPS-inducible genes on the basis of 
transcriptome analysis of WT, Reg1–/–; RoquinSan/San, Reg1–/– and RoquinSan/San MEFs. 
(F) GSEA of overlap between Reg1 (left) or Roquin (right) target genes (RIP-seq based) 
and RoquinSan/San enrichment (transcriptome analysis based). An ES plot is shown with 
genes ranked according to their RoquinSan/San enrichment p value. In lower panels, the 
ranks of Reg1 (left) or Roquin (right) target genes are indicated (blue lines). 
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Legends for Supplementary Tables. 
Table S1. RNA sequencing data from Reg1 IP experiments, related to Figure 1 
 
Table S2. Gene ontology (GO) annotations enriched for the 68 Reg1-interacting 
mRNAs, Related to Figure 1 
 
Table S3. RNA sequencing data from Roquin-1 IP experiments, Related to Figure 2 
 
Table S4. RNA sequencing data from Reg1 HITS-CLIP experiments, Related to 
Figure 2 
 
Table S5. Ribosome is a candidate complex as Reg1-associated complex, Related to 
Figure 5 
Proteins enriched by iTRAQ-based proteomic identifying as Reg1-associated proteins. 
Control or Flag-Reg1 immunoprecipitates from RAW cells was labeled with iTRAQ 
reagent 114 or 117, respectively. The contents of each iTRAQ reagent-labeled sample 
were combined and analyzed by LC-MS/MS. Based on a 80% confidence level (< 20% 
117/114 variability), cutoff values of 1.2-fold for up-regulated proteins were used to 
define candidate proteins as Reg1-associated proteins. 
 
Table S6. Transcriptome analysis from Reg1–/–; RoquinSan/San double mutant MEFs, 
Related to Figure 7 
 
Table S7. Primers used for quantitative PCR analysis and the preparation of 






















































































































































































































































mouse 1203 CCGUUUCUCGUGGUCACUUUACUACGAGAAACGC 1236
human 1255 UUUCUUCUUUUAGCCAUUUUGCUAAGAGACACAG 1288
Macac 1255 UUUCUUCUUUUAGCCAUUUUGCUAAGAGACACAG 1288
Pan   1255 UUUCUUCUUUUAGCCAUUUUGCUAAGAGACACAG 1288
Horse  396 UCAUUUCUCUUAGCCAUUUUGCUAAGAGAAACUC 429
****    * ** * *      *** **
Loop
mouse 100 GUUGUUUCUAUGAAACAAACCCAUUUAGUUCACUAUUAUAUAGUGGAUUAU 150
human  99 GUUGUUUCUAUGAAACAAACAUAUUUAGUUCACUAUUAUAUAGUGGGUUAU 149
Macac  99 GUUGUUUCUAUGAAACAAACAUAUUUAGUUCACUAUUAUAUAGUGGGUUAU 149
Pan    99 GUUGUUUCUAUGAAACAAACAUAUUUAGUUCACUAUUAUAUAGUGGGUUAU 149
Horse  98 GUUGUUUCUAGGAAACAAACAUAUUUAGUUCACUAUUAUAUAGUGGGUUAU 148





Nfkbiz 102-120 Nfkbiz 130-149
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Max. ES score: 
0.2825
p < 10–4
Rank in ordered dataset
0
0.20













Genes enriched in Reg1 RIP-seq
Max. ES score: 
0.2830
p ~ 2 x 10–4
Rank in ordered dataset
0
0.20






Genes enriched in Roquin RIP-seq























Roquin San/San; Reg1 –/–
Reg1 –/–
Roquin San/San
Rank Gene ontology term (biological process) Pvalue OddsRatio ExpCount Count Size ID
1 response to wounding 1.32E-08 6.333951 4.25545675 19 1128 GO:0009611
2 inflammatory response 4.47E-08 8.585926 1.94664511 13 516 GO:0006954 
3 response to molecule of bacterial origin 1.36E-07 13.040962 0.84128267 9 223 GO:0002237 
4 positive regulation of smooth muscle cell proliferation 3.32E-07 42.543253 0.14713015 5 39 GO:0048661 
5 regulation of nitric oxide biosynthetic process 4.87E-07 39.085851 0.15844786 5 42 GO:0045428 
6 response to bacterium 9.06E-07 8.863915 1.37321477 10 364 GO:0009617 
7 cardiovascular system development 1.15E-06 5.906329 3.0331447 14 804 GO:0072358 
8 circulatory system development 1.15E-06 5.906329 3.0331447 14 804 GO:0072359 
9 response to lipopolysaccharide 1.20E-06 11.915033 0.79978442 8 212 GO:0032496 
10 nitric oxide biosynthetic process 1.45E-06 30.748853 0.19617354 5 52 GO:0006809
Table S2. Functional Categories of Reg1 target genes discovered by RIP-Sequencing analysis.
RAW cells
Accession No. Protein Name Fold Change(117/114) 117/114 Variability [%]
Q5D1E7 Zinc finger CCCH domain-containing protein 12A (Zc3h12a) 4.618 3.8
P17156 Heat shock-related 70 kDa protein 2 (Hspa2) 1.433 0.7
Q9D8E6 60S ribosomal protein L4 (Rpl4) 1.371 4.3
P62267 40S ribosomal protein S23 (Rps23) 1.369 13.6
P62274 40S ribosomal protein S29 (Rps29) 1.322 7.4
P05213 Tubulin alpha-1B chain (Tuba1b) 1.320 0.6
Q9EPU0 UPF1 regulator of nonsense transcripts homolog (Upf1) 1.292 15.2
Q8VC57 BTB/POZ domain-containing protein KCTD5 (Kctd5) 1.288 0.8
P61255 60S ribosomal protein L26 (Rpl26) 1.288 6.4
Q9JMH9 Myosin-XVIIIa (Myo18a) 1.278 5.0
Q03265 ATP synthase subunit alpha, mitochondrial (Atp5a1) 1.275 8.6
P62702 40S ribosomal protein S4, X isoform (Rps4x) 1.262 6.6
P62908 40S ribosomal protein S3 (Rps3) 1.249 2.3
P14131 40S ribosomal protein S16 (Rps16) 1.227 4.3
P67984 60S ribosomal protein L22 (Rpl22) 1.221 11.7
P35980 60S ribosomal protein L18 (Rpl18) 1.214 1.4
Q8BGD9 Eukaryotic translation initiation factor 4B (Eif4b) 1.209 14.2
P56959 RNA-binding protein FUS (Fus) 1.207 1.1
P25444 40S ribosomal protein S2 (Rps2) 1.202 10.3
P20029 78 kDa glucose-regulated protein (Hspa5) 1.201 1.0
Q9JHJ0 Tropomodulin-3 (Tmod3) 1.200 6.6
P62900 60S ribosomal protein L31 (Rpl31) 1.200 5.3
Table S5. Ribosome and UPF1 is a candidate complex as Reg1-associated complex, related to Figure 5
Proteins enriched by iTRAQ-based proteomic identifying as Reg1-associated proteins. Control or Flag-Reg1
immunoprecipitates from RAW cells was labeled with iTRAQ reagent 114 or 117, respectively. The contents of
each iTRAQ reagent-labeled sample were combined and analyzed by LC-MS/MS. Based on a 80% confidence
level (< 20% 117/114 variability), cutoff values of 1.2-fold for up-regulated proteins were used to define
candidate proteins as Reg1-associated proteins.
List of primers
Table S7. Primers used for quantitative PCR analysis
Gene Sequence (5′ to 3′)
Mouse Il6 (Forward) GTAGCTATGGTACTCCAGAAGAC
Mouse Il6 (Reverse) ACGATGATGCACTTGCAGAA
Mouse Tnf (Forward) CCCTCACACTCAGATCATCTTCT
Mouse Tnf (Reverse) GCTACGACGTGGGCTACAG
Mouse Zc3h12a (Forward) CGAGAGGCAGGAGTGGAAAC
Mouse Zc3h12a (Reverse) CTTACGAAGGAAGTTGTCCAGGCTAG
Mouse Roquin (Rc3h1) (Forward) GACCAGACCACTATCAATACGGAC
Mouse Roquin (Rc3h1) (Reverse) CACTGCTGAGTGGCTTCAGGTAC
Mouse Roquin2 (Rc3h2) (Forward) CACTAGGAGAAAGAACTGTGAC
Mouse Roquin2 (Rc3h2) (Reverse) GCAGAACCATCTTCTAATGCCAGC
Mouse Nfkbiz (IkBz) (Forward) CTCCGACTCCTCCGATTTCTC
Mouse Nfkbiz (IkBz) (Reverse) GCTTGTTGCTTCGGATGTGTAG
Mouse Nfkbid (IkBNS) (Forward) GAGCTCACATATTGGCTCTG
Mouse Nfkbid (IkBNS) (Reverse) GAATATCCAGCTGTCGGTAC
Mouse Ptgs2 (Forward) CTTGCTGTTCCAATCCATGTC
Mouse Ptgs2 (Reverse) GTTCCAGACTCCCTTGAAGTG
Mouse Icos (Forward) GTGTCTTTGTCTTCTGCTTC
Mouse Icos (Reverse) GAGGACTTCTCTCTCTCTGAAC
Mouse UPF1 (Forward) GCTGAACTTCGAGGAAGATG
Mouse UPF1 (Reverse) CTTCCTTGCATTTTGCCCTC
Mouse UPF2 (Forward) CATTAGTCCGGAGAAGCAGC
Mouse UPF2 (Reverse) GTGCCTGTCCTCACTTAGCTC
Mouse UPF3x (Forward) GGACCGATTTGATGGCTATG
Mouse UPF3x (Reverse) CATTGTCTGTGGCATAACTCTC
Mouse Cxcl-1 (Forward) CCATGGCTGGGATTCACCTC
Mouse Cxcl-1 (Reverse) CTCCGTTACTTGGGGACACC
Mouse Cxcl-2 (Forward) CTGTCAATGCCTGAAGACCCTG
Mouse Cxcl-2 (Reverse) CTCCTTTCCAGGTCAGTTAGC
Mouse Cxcl-3 (Forward) CTGTTGTGGCCAGTGAGCTG
Mouse Cxcl-3 (Reverse) GATGATTATCTGAAGCCTGG
Mouse Nfkbia (IkBa) (Forward) GAGGAGTACGAGCAAATGGTG
Mouse Nfkbia (IkBa) (Reverse) CCTGACCAATGACTTCCATG
Mouse Gas5 (Forward) CAGGTATTAATGGGTCACCTC
Mouse Gas5 (Reverse) CTTCTATTTGAGCCTCCATCC
Mouse Smg5 (Forward) CAGAGAACGTTAGCCTGAGG
Mouse Smg5 (Reverse) CTGTAGGCACATTCCAAGGTG
Mouse Mafk (Forward) CTAATCCCAAGCCCAACAAG
Mouse Mafk (Reverse) GTAGCCTCTGTTCTTGAGTGTG
Mouse Stau1 (Forward) GCTGTTCTGGAGCAGCTTAG
Mouse Stau1 (Reverse) CCTGCTGGATCTGTGCAAGTC
Mouse -Actin (Forward) GGCTGTATTCCCCTCCATCG
Mouse -Actin (Reverse) CCAGTTGGTAACAATGCCATGT
List of primers (continued)
Table S7. Primers used for quantitative PCR analysis (continued)
Gene Sequence (5′ to 3′)
Human IL6 (Forward) CAGCCACTCACCTCTTCAGAAC
Human IL6 (Reverse) GCATCCATCTTTTTCAGCCATCTTTGG
Human TNF (Forward) CTGCCTGCTGCACTTTGGAGTG
Human TNF (Reverse) CATTGGCCAGGAGGGCATTGG
Human PTGS2 (Forward) CATGTCAAAACCGAGGTGTATG
Human PTGS2 (Reverse) GAAGTGGGTAAGTATGTAGTGCAC
Human ICOS (Forward) CTTGGACCATTCTCATGCCAAC
Human ICOS (Reverse) GCATCCCAAAATGCAGACTAC
Human ZC3H12A (Forward) GAAGAGGAAAAGGAGGGCAG
Human ZC3H12A (Reverse) CTCCAGGATGGCACAAACAC
Human Roquin (RC3H1) (Forward) GGTTGTGGCCATACTGTCTG
Human Roquin (RC3H1) (Reverse) GCTTTGTGTCTTCAACCCCAC
Human Roquin2 (RC3H2) (Forward) GACCAGACTGCCATCAACAC
Human Roquin2 (RC3H2) (Reverse) GTAGAGTGCCAAATCCTCAACG
Human NFKBIZ (IkBz) (Forward) GAAAGGGCCCGATTCGTTGTCTG
Human NFKBIZ (IkBz) (Reverse) GAAGCAGATCAGCACTGCTCTC
Human NFKBID (IkBNS) (Forward) CTCCTGACTTCTACCCACCCTC
Human NFKBID (IkBNS) (Reverse) CCAAAGCCAGCATGTGAGCTC
Human UPF1 (Forward) GTTGAACTTCGAGGAAGATG
Human UPF1 (Reverse) CATTTTGCCCTCACAAGGTG
Human UPF2 (Forward) CAGAGAAACAACAGCCCTTC
Human UPF2 (Reverse) CAGCTTCTGGTAAGACATAGC
Human UPF3x (Forward) GAAGATAAGCAGGATCGCAAC
Human UPF3x (Reverse) GTTGATGTATGCTCTGGCATAC
Human CXCL-1 (Forward) GAATTCACCCCAAGAACATC
Human CXCL-1 (Reverse) CTTCTGGTCAGTTGGATTTG
Human CXCL-2 (Forward) GAACTGCGCTGCCAGTGCTTG
Human CXCL-2 (Reverse) GATTTTCTTAACCATGGGCGATG
Human CXCL-3 (Forward) GTGGTCACTGAACTGCGCTG
Human CXCL-3 (Reverse) GATTTTCTGAACCATGGGGGATG
Human NFKBIA (IkBa) (Forward) GAGGAGTACGAGCAGATGGTC
Human NFKBIA (IkBa) (Reverse) CAGGTTGTTCTGGAAGTTGAG
Human GAS5 (Forward) GTGTGGCTCTGGATAGCACC
Human GAS5 (Reverse) GAACCATTAAGCTGGTCCAGG
Human SMG5 (Forward) GTGCATCGACTTGACCTCATC
Human SMG5 (Reverse) GTATACCTTTCTCCACAGCAG
Human MAFK (Forward) CGACTAATCCCAAACCGAATAAGG
Human MAFK (Reverse) GTTCTTGAGTGTGCGCCGAC
Human STAU1 (Forward) CTTACTCTCGGATGCAGTCCAC
Human STAU1 (Reverse) GATCCTCAACGCTTTGGCAG
Human -ACTIN (Forward) CACCATTGGCAATGAGCGGTTCC
Human -ACTIN (Reverse) CTTCTGCATCCTGTCGGCAATGC
Firefly Luciferase (Forward) CTGGAAGATGGAACCGCTGGAG
Firefly Luciferase (Reverse) CACTGCATACGACGATTCTGTG
Renilla Luciferase (Forward) GGATGATAACTGGTCCGCAG
Renilla Luciferase (Reverse) CACCGCGCTACTGGCTCAATATG
List of primers (continued)
Gene Sequence (5′ to 3′)
Mouse Il6 CDS (Forward) GTTCCTCTCTGCAAGAGACTTCCATCC
Mouse Il6 CDS (Reverse) GTATCTCTCTGAAGGACTCTGGCTTTG
Mouse -Actin CDS (Forward) CTATGTGGGTGACGAGGCCCAGAG
Mouse -Actin CDS (Reverse) GGGTACATGGTGGTACCACCAGAC
Human UPF1 CDS (Forward) CTGTGGACGACAGTGTAGCCAAGAC
Human UPF1 CDS (Reverse) GAGCTGTCCCAGTTGATGTCCTTGAG
Mouse -Globin CDS (Forward) CACCTGACTGATGCTGAGAAGGCTG
Mouse -Globin CDS (Reverse) CTTCTGGAAGGCAGCCTGTGCAG
Table S7. Primers used for the preparation of Northern blot probes
